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Det er utviklet og patentert en tredimensjonal ultralyd Doppler metode (multibeam high pulse 
repetition frequency color Doppler eller MULDO) for kvantitering av klaffelekkasjer. Ved 
hjelp av Doppler kan blodstrøms hastigheter måles. Ved en klaffelekkasje vil den smaleste 
delen av blodstrømmen gjennom en defekt kalles vena contracta der alt blodet har samme fart 
(laminær blodstrøm). Maksimale blodhastigheter i vena contracta er typisk mellom 4 og 6 
m/s, som er høyere enn det pulset Doppler kan måle. Vi benytter HPRF (high pulse repetition 
frequency) for å kunne måle Doppler-signalet fra vena contracta. Styrken i Dopplersignalet 
(Doppler power) er proporsjonalt med størrelsen på lekkasjedefekten (vena contracta areal) og 
måles ved hjelp av mange ultralydbølger (multibeam) og kalibreres ved hjelp av en 
referansebølge med gitte egenskaper. I studie 1 ble metoden testet i simuleringsforsøk og i 
laboratorium samtidig som vi gjorde kliniske pilotforsøk for å se om metoden kunne brukes 
på pasienter.  I studiene 2 og 3 ble metoden testet hos pasienter med hhv. mitral- og aortaklaff 
lekkasje.  For å beregne lekkasjevolum brukte vi produktet av vena contracta arealet ved 
MULDO og hastighet-tidsintegralet av lekkasjejeten ved kontinuerlig Doppler. Det var 
rimelig bra samsvar med referansemetoder som todimensjonal Doppler ultralyd og magnetisk 
resonans imaging (MRI) hos pasienter med moderat og stor lekkasje, men metoden 
overestimerte små lekkasjer. Dette var i samsvar med simulering-og laboratorieresultater fra 
studie 1 som skyldes begrensninger i romlig oppløsning av metoden.  
Konklusjon: MULDO kan brukes som supplement til andre Doppler parametre for 
kvantifisering av moderat til alvorlig mitral- og aortaklaff lekkasje. Vi tror kombinasjoner 
med nyere teknikker med parallell stråleforming kan forbedre 3D kvantifisering av 
klaffelekkasjer. 
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Abbreviation list 
AR = aortic regurgitation 
CW = continuous wave 
EF = ejection fraction 
ERO area = effective regurgitant orifice area 
Eq. = Equation 
HPRF = high pulse repetition frequency 
LVEDd = left ventricular end-diastolic dimension 
LVESd = left ventricular end-systolic dimension 
M-mode = motion mode 
MRI = magnetic resonance imaging 
MR = mitral regurgitation 
MULDO = multibeam high pulse repetition frequency color Doppler 
PISA = proximal isovelocity surface area 
PRF = pulse repetition frequency 
PW = pulsed wave 
Reg. vol. = regurgitant volume 
ROI = region of interest 
TEE = transesophageal echocardiography 
TTE = transthoracic echocardiography  
VCA = vena contracta area 
VCW = vena contracta width 
VTI = velocity time integral 
2D = two-dimensional  
3D = three-dimensional  
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1 Introduction 
1.1 Echocardiography 
1.1.1 Selected history 
For a wide range of cardiac diseases there is a need for non-invasive tools to assess and 
quantify disease processes. The development of cardiac ultrasound started in Sweden with the 
first description of an ultrasonic reflectoscope by Edler and Hertz in the early 1950s to obtain 
echoes from cardiac structures,1 and later two-dimensional echograms of the heart by Hertz 
and Åsberg.2, 3 In the 1960s Feigenbaum used ultrasound to visualize the left ventricle and 
measure wall thickness.4 In 1976 Holen and Åslid investigated the pressure gradients in mitral 
stenosis by Doppler.5 Omoto et al. demonstrated color Doppler in valvular regurgitation.6   
The ultrasound research group in Trondheim pioneered by Bjørn Angelsen and Liv Hatle 
made important contributions in establishing Doppler methods. In 1976, Bjørn Angelsen and 
colleagues developed PEDOF (Pulsed and continuous wave Doppler) which was validated by 
Liv Hatle et al. in mitral valve diseases,7, 8 aortic stenosis,9 and for systolic pulmonary artery 
pressure.10 Vingmed included Doppler into a two-dimensional echo scanner in 1982 and color 
Doppler in 1986. In 1984, Ihlen et al. from the research group in Oslo demonstrated that 
cardiac output could be calculated by Doppler.11 There were further studies by Hegrenæs and 
Skjærpe in Trondheim in 1985 and 1986, validating Doppler in aortic stenosis for the 
assessment of severity,12, 13 and for the estimation of systolic pressure in the right ventricle in 
patients with tricuspid regurgitation.14 In 1993, Rossvoll and Hatle validated pulmonary 
venous flow velocities for estimation of left ventricular end-diastolic pressure.15 Strain rate 
imaging by Doppler was developed and validated by Heimdal and Støylen.16, 17     
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1.1.2 Principles of ultrasound 
Ultrasound is sound waves with a frequency higher than the range of human hearing, and can 
be characterized by its frequency (f), wavelength (λ) and amplitude (intensity). Medical 
ultrasound transducers typically use frequencies between 1 and 20 MHz. The propagation 
velocity (c) of sound in the heart is about 1540 m/s. The relation between the wavelength (λ), 
frequency (f) and propagation velocity (c) of the ultrasound wave in the heart; given by Eq. 1: 
. 1)		 ∙ 	 =  
Sound waves move along a straight beam that can be focused. When sound waves 
reach a medium with different acoustic properties, they will be reflected at the boundaries. 
However, small structures (< 1 wavelength) such as blood cells result in scattering of the 
ultrasound signal in all directions. The amplitude of the sound wave is in decibels, and the 
amplitude of the received ultrasound signal is dependent on the transmitted amplitude, 
acoustic impedance of the tissues, the depth (R) and the transmitting frequency. Ultrasound is 
generated by piezoelectric crystals in the transducer, which induce expansion and 
compression from electric signals, and the reflected or backscattered echoes are converted to 
electric signals. The time (t) between the transmission and return of echoes determines the 
depth (R) of the reflecting object, Eq. 2:18  
. 2)	2	 ∙  =  ∙  
 
1.1.3 Spatial resolution  
The radial resolution is dependent on the length of the transmitted ultrasound pulse, with a 
higher transducer frequency allowing a shorter pulse and improved resolution. The lateral 
resolution is dependent on the width of the ultrasound beam which is proportional to the 
wavelength and the focal depth and is inversely proportional to the transducer diameter.18, 19 
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1.1.4 Basic principles of Doppler 
Doppler echocardiography is based on detection of the Doppler shift from moving structures 
such as red blood cells or myocardium. If the ultrasound is backscattered from moving 
structures, there will be a change in frequency, and the difference in frequency between the 
backscattered (f) and transmitted (f0) signals is the Doppler shift. When the structure is 
moving toward the transducer, the backscattered frequency is higher than the transmitted 
frequency, and the Doppler shift is positive. When the structure is moving away from the 
transducer, the backscattered frequency is lower and the Doppler shift is negative. The 
relation between the Doppler shift (fd) and blood flow velocity (v) is given by Eq. 3: 
. 3)		 = 	 −		 = 2	 ∙ 		 ∙ 	 cos  	 
This is the Doppler equation, and θ is the angle between the ultrasound beam and the 
direction of the blood flow. The radial velocities are calculated, and the ultrasound beam 
should be aligned as parallel with the direction of the blood flow as possible so that θ is close 
to 0º and cos θ can be assumed to be 1. Alignment is important as a θ of 20 ̊, 40 ̊ and 60 ̊ will 
cause an underestimation of the flow velocity of 6%, 23% and 50%, respectively.  
1.1.5 Grey scale imaging 
In grey-scale imaging the amplitude is displayed as brightness of the scatterers versus depth. 
By repeating pulse transmission and receiving cycles along one scan line and recording time 
along the horizontal axis, there is a motion (M-) mode (see the left part of Figure 1). In two-
dimensional (2D) imaging, a pulse is transmitted along a scan line, waiting for echoes to 
return, and then the next pulse is rotated in a step-wise manner to make up another scan line 
by a phased array probe (see the right part of Figure 1). Frame rate is determined by the scan 
depth (R) and number of scan lines.18, 19 A reduction of the number of scan lines will increase 
the frame rate at the cost of poorer lateral resolution.  
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Figure 1: Left: M-mode imaging along one beam (red line) through the mitral valve vs. time. Right: One frame of 2D imaging of the heart 
made up of several scan lines (red lines).   
 
1.1.6 Pulsed wave and continuous wave Doppler 
In pulsed wave (PW) Doppler the blood flow velocities from a specific depth are sampled; 
this is called the sample volume. An ultrasound pulse of short duration is transmitted and, 
after an interval determined by the depth of interest, the backscattered signal is sampled or 
received at the transducer. The length of the sample volume is determined by the duration of 
the pulse, and the width of the beam corresponds to the width of the sample volume. Another 
pulse of ultrasound can be beam transmitted when the first one is received at the transducer, 
and the interval of time (t) between the pulses is dependent on the depth to the sample volume 
(R), as demonstrated in Eq. 2. The frequency of pulses is called the pulse repetition frequency 
(PRF). For PW Doppler, there is a maximum limit to velocity that can be measured 
unambiguously, called the Nyquist limit. The maximum detectable Doppler shift (fd) is equal 
to half of the PRF. The Nyquist limit (VNy) is given by Eq. 4: 
Eq. 4)	 =	 c

8	 ∙ f 	 ∙ R	 ∙ cos	θ 
If the velocity of interest exceeds the Nyquist limit, there is signal aliasing, giving 
incorrect information of the direction and velocity. As the PRF is successively increased, 
using high pulse repetition frequency (HPRF), the Nyquist limit is increased, but there will be 
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more sample volumes and range ambiguity. By transmitting and sampling continuously, 
continuous wave (CW) Doppler high velocities can be measured without aliasing. Velocities 
are measured from any depth, and there is no range resolution. 
The frequency content of the Doppler signals is displayed as spectral analysis, with 
time versus velocities, as shown in Figure 2. Blood flow direction towards and away from the 
probe is displayed as positive and negative velocities. The intensity of the velocity spectrum 
indicates the amplitude of the Doppler signals and the amount of moving blood cells.18-20  
 
 
Figure 2: Left: PW Doppler of the laminar flow of the mitral inflow measured at the tip of the mitral leaflets, one sample volume (red box), 
displays a narrow spectral signal (narrow bandwidth). Right: CW Doppler of severe mitral regurgitation measuring velocities from any 
depth along the beam (red line), up to 4 m/s in this case, including turbulent flow. 
.  
1.1.7 Color Doppler imaging 
In Color Doppler, there are multiple sample volumes along each scan line. An ultrasound 
pulse is transmitted, and the Doppler signals from each sample volume are received. Several 
pulses (3 – 15) along each scan line are used, and the estimation of flow velocities is made 
from the Doppler signals   
The Doppler signal amplitude has high values inside blood flow and low values 
outside flow. In laminar flow with narrow bandwidth, the mean frequency gives information 
of the velocity. The radial velocity data at each depth are encoded in color showing flow 
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towards the transducer as red and away from the transducer as blue. If the Nyquist limit is 
exceeded, the color shifts from red to blue or vice versa. Turbulent flow with high velocities 
causes multiple aliasing and uncertainty in determining the velocity. Turbulent flow is 
displayed by including green/yellow with red/blue to the color-coding. Color Doppler 
imaging is shown in Figure 3. 
 
 
Figure 3: Color Doppler imaging, adapted from Hans Torp. 
 
The Nyquist limit is determined by the scan depth (R). The frame rate is determined by the 
scan depth, the number of scan lines and the number of ultrasound pulses along each scan 
line. The sensitivity to detect blood flow is dependent on the number of scan lines.18-20 
1.1.8 Power Doppler  
In power Doppler, there are multiple sample volumes along each scan line, similar to color 
Doppler, but the signal processing differs. The power of the Doppler signal is proportional to 
the amount of moving red blood cells, independent of flow direction and velocity.18, 20    
Mitral inowAortic regurgitant jet
No color
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1.1.9 Three dimensional imaging 
The ultrasound beam is transmitted in a similar way as a 2D scan and then repeated 
successively in a fan-like manner in the elevation plane to make a pyramid-shaped 3D 
volume, as demonstrated in Figure 4, using matrix array probe technology.   
 
 
Figure 4: Left: Matrix array probe adapted from Hans Torp, typically with about 2400 elements for beam forming, steering and focusing in 
the azimuthal and elevation plane. Right: Pyramidal-shaped 3D volume visualizing the mitral valve in one diastolic volume.  
 
For 3D imaging, the volume rate can be improved by limiting the number of scan lines 
at the cost of poorer spatial resolution. These limitations can be addressed by acquiring 
subvolumes for each R-R interval and then stitching these subvolumes (typically 4 - 7) to 
produce a full volume dataset. One major limitation is stitching artefacts. Color Doppler is 
implemented in 3D imaging, and the limitations are those inherent for both techniques.21  
 
1.2 Mitral regurgitation 
1.2.1 Background 
The prevalence of moderate to severe valvular heart disease in the USA has been reported to 
be as high as 2.5%, with mitral regurgitation (MR) being the most common (1.7%) lesion.22 In 
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Europe, MR has been reported to be the second most common form of valvular heart disease 
needing surgery.23 
The anatomy of the mitral valve is shown in Figure 5, and dysfunction of any of these 
structures can cause abnormal leaflet coaptation and MR of varying degree.24  
 
 
Figure 5: Parasternal long axis and short axis views of the mitral valve The posterior mitral leaflet is divided into three scallops: 
anterolateral (P1), middle (P2) and the posteromedial scallop (P3). The opposing segments of the anterior leaflet are defined as A1, A2 and 
A3. The base of the leaflets is attached to the annulus (mitral annular plane is marked in red) and the areas where the two leaflets come 
together at their insertion are the posteromedial and anterolateral commissures (PM and AL). When the mitral valve is closed the line of 
contact between the leaflets is called the coaptation line (marked in orange), and the leaflets overlap by several millimeters (coaptation 
length is marked in yellow) to ensure valve competency. The chorda tendinea originate from the papillary muscles and insert into the leaflets 
to prevent prolapse.  
 
Carpentier introduced a functional classification of MR based on leaflet movement:24, 25 
Type 1: Normal valve movement: annular dilatation or leaflet perforation.  
Type 2: Excessive movement: billowing, mitral valve prolapse or flail. 
Type 3a: Systolic and diastolic restriction. 
Type 3b: Systolic restriction.  
In primary (organic) MR, there is a primary valve lesion. In western countries, the 
most common etiology of primary MR is degenerative mitral valve disease (myxomatous 
degeneration and fibroelastic deficiency), resulting in billowing (see the left part of Figure 6) 
or a mitral valve prolapse. If there are rupture of chords, a portion of the mitral valve becomes 
A1
AA2
A3
P3
P2
P1
 
 
AL
PM 
A2
P2
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flail, which results in incomplete coaptation and leaflet diastasis.26 These lesions represent a 
type 2 dysfunction.  Rheumatic disease and endocarditis are less common. There is typically a 
type 3a dysfunction in rheumatic disease and type 1 or 2 dysfunction in endocarditis.   
In secondary (functional) MR, there is primary myocardial disease. The most common 
etiology of secondary MR is ischemic heart disease.27, 28 In left ventricular global remodeling, 
there is apical and inferior displacement of the papillary muscles together with non-extensible 
chorda resulting in symmetrically tethered and apically displaced leaflets as well as flattening 
and dilatation of the mitral annulus. As demonstrated in the right part of Figure 6, the 
deformation of the mitral valve can be quantified by the degree of tenting of the leaflets.29, 30 
Localized left ventricular remodeling, such as in basal inferoposterior infarctions, can result in 
asymmetric leaflet tethering.31 These changes cause a type 3b dysfunction.  
  
 
Figure 6: Left: Billowing of the mitral valve in Barlow’s disease. Both leaflets protrude below the annular plane (red); however, the 
coaptation (yellow) is preserved above the annular plane. In mitral valve prolapse, the coaptation is below the annular plane.  
Right: Symmetrical tethering resulting in tenting of the mitral leaflets in dilated cardiomyopathy. The distance between the annular plane 
and the point of coaptation (yellow) is the coaptation distance (blue). The systolic tenting area is the area between the coaptation point, the 
leaflets and the annular plane (red triangle). The coaptation length is reduced. 
  
1.2.2 Hemodynamic consequences and outcome of mitral regurgitation 
In acute disease, the regurgitant volume ejected into a normal-sized left atrium results in 
markedly increased left atrial and pulmonary pressures together with reduced stroke volume 
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by a normal-sized left ventricle.32 In chronic compensated primary disease, there is a gradual 
eccentric remodeling of the left ventricle and atrium in response to volume overload. Severe, 
long-standing MR can result in an increase in left atrial and pulmonary pressures and 
irreversible myocardial damage. In patients with MR due to flail leaflet treated medically, 
there was an annual incidence of heart failure of 6.3% and a 10 year-incidence of 63%.33 In 
secondary MR, the pathophysiology and outcome is different since this is a myocardial 
disease.34 
1.2.3 Assessment of severity of mitral regurgitation by 2D Doppler 
The echocardiographic assessment of the severity of MR is performed by TTE as an 
integrated approach. Color Doppler is sensitive for diagnosing MR, but the jet area is not 
recommended to quantify the severity of MR. Semi-quantitative approaches by PW Doppler 
such as the dimensionless ratio of mitral inflow to left ventricular outflow VTI in primary MR 
and the pulmonary venous flow patterns are additional parameters to assess severity; however, 
these are influenced by the left atrial filling pressure or atrial fibrillation. Quantitative 
approaches provide the regurgitant volume and the effective regurgitant orifice area (ERO 
area).35-39 
Quantitative Doppler is time-consuming, requiring several steps of calculation, and is 
not recommended as a first line method. The PISA method is recommended for 
quantification, and its principle is based on the continuity principle.39 As blood approaches a 
circular orifice, its velocity increases, forming concentric and hemispheric shells of increasing 
velocity and decreasing surface area, visualized as proximal flow convergence zones. The 
flow in each of these hemispheres equals the flow through the orifice. Color Doppler offers 
the ability to visualize one of these hemispheres corresponding to the Nyquist limit by 
adjusting the baseline shift to optimize visualization. Color flow M-mode imaging of a 
proximal flow convergence zone is shown in Figure 7.   
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Figure 7: Dynamic changes of flow rate (early systolic peak and gradual decrease) during systole using color M-mode of the proximal flow 
convergence in functional MR. 
 
 
The PISA is measured at mid-systole corresponding to maximal velocity (Vmax) of the 
regurgitant jet by CW Doppler. The calculations are shown: Eq. 5, 6, 7, 8 and Figure 8.39, 40 
 
. 5)	$%&' = 2 ∙ 	( ∙ 	 
 
. 6)	*+,-	./0 = $%&'	 ∙ '+1/2134	0+,15 
 
. 7)	789:8 =	*+,-	./0;8<  
 
. 8)	04=.41/3	,+=>0 = 7	89:8 	 ∙ 	?%	 
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Figure 8: Upper: A proximal flow convergence zone is visualized by color Doppler imaging at the transition from blue to 
red/yellow corresponding to blood flow velocity of 26 cm/s, called the aliasing velocity. The proximal isovelocity surface area (PISA) is 
calculated as the surface area of a hemisphere, marked as a red hemisphere with a radius (R) marked in black. Flow rate is found by 
multiplying the PISA with the aliasing velocity. Lower: CW Doppler of the mitral regurgitant flow to find the VTI, marked by a red envelope, 
and Vmax and to calculate both the ERO area and regurgitant volume. 
 
Quantitative parameters have demonstrated prognostic value in primary MR with 
worse outcome in those with an ERO area ≥ 40 mm2 and regurgitant volume ≥ 60 mL.41 In 
secondary MR an ERO area ≥ 20 mm2 and regurgitant volume ≥ 30 mL are associated with 
worse outcome.42-44 
 It is recommended to get the best possible alignment between flow and the ultrasound 
beams, usually from the apical view. In eccentric jets, there will also be misalignment of flow 
and Doppler signals causing errors and limiting the use of the PISA-method.39, 40 There is 
R
VTI
Vmax.
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dynamic variation of the mitral regurgitant flow rate and the ERO area during systole, which 
is demonstrated in Figure 7. In secondary MR, there is typically an early and late systolic 
peak and mid-systolic decrease or an early peak followed by a gradual decrease in flow rate, 
in rheumatic disease the flow is relatively constant until a decrease in end-systolic and in 
mitral valve prolapse there is a late-systolic increase of the flow rate.45, 46 Time integral PISA 
methods have been introduced; however, these are cumbersome.47 
Another approach to quantify MR is the vena contracta. As a regurgitant jet passes 
through an anatomic orifice, the jet continues to constrict for a certain distance before it 
expands radially into the receiving chamber. The vena contracta is the narrowest portion of 
the regurgitant jet downstream to the anatomic orifice and corresponds to the physiologic 
orifice or effective regurgitant orifice (ERO), which is slightly smaller than the anatomic 
orifice.48 Both the shape of the proximal flow convergence and the vena contracta are defined 
by the geometry of the anatomic orifice, and the vena contracta area (VCA) is equivalent to 
the physiologic orifice area or ERO area. Making assumptions that the geometry of the 
anatomic orifice is perfectly circular, the flow convergence zone will form a 3-dimensional 
hemispheric shape on which the PISA formula is based, and the vena contracta will be 
circular.49  
The vena contracta is typically viewed and measured perpendicular to the mitral 
commissural line, such as in the parasternal long axis or apical 4-chamber to measure the vena 
contracta width (VCW), as demonstrated in Figure 9. A Nyquist limit of 50 – 70 cm/s is 
recommended. The color sector should be as narrow as possible to maximize lateral and 
temporal resolution. As there is dynamic variation of the ERO area and thus the vena 
contracta, depending on the etiology, each systolic frame should be examined to identify the 
frame with the largest diameter of the vena contracta.39, 40, 50  
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 Figure 9: The proximal flow convergence (PFC), vena contracta (VC) and turbulent jet of a regurgitant jet are visualized.  
 
Assuming that the vena contracta is circular, an estimate of ERO area would be, Eq. 9: 
. 9)	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In noncircular jets the 2-chamber view of the vena contracta will overestimate the MR 
severity (see Figure 10). According to guidelines, a vena contracta width (VCW) ≥ 7 mm 
along the long-axis plane or a mean VCW (4-chamber and 2-chamber) > 8mm is regarded as 
a specific sign of severe MR.51, 52   
VC
PFC
Turbulent ow
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Figure 10: A short axis view of the mitral valve leaflets and the corresponding long-axis plane, while the two-chamber plane is parallel to 
the commissural line. The vena contracta width (VCW) will appear different in the long-axis and 2-chamber views in asymmetric jets.   
 
1.2.4 Assessment of severity of mitral regurgitation by 3D Doppler 
Real-time 3D Doppler echocardiography has demonstrated that the PISA is hemielliptic rather 
than hemispheric in secondary MR, resulting in underestimation of the ERO area by the 
hemispheric approach. PISA can be calculated from a hemielliptic surface area formula using 
the 3D dataset to measure the PISA radius, width and length.53-55 The regurgitant flow rate is 
calculated from the hemielliptic (HE) PISA and the aliasing velocity, Eq. 10. The ERO area 
and regurgitant volume is calculated from flow rate, the peak velocity and VTI of the 
regurgitant jet by CW Doppler, similar to Eq. 7 and 8: 
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Direct and automated measurement of 3D PISA is feasible making no geometric 
assumptions.56 A time-integrated automated PISA method, Eq. 11, in patients with secondary 
MR, was more accurate than using only one frame (volume) to calculate the regurgitant 
volume; N= number of systolic color Doppler volumes.57 
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A 3D color Doppler method to calculate mitral inflow and aortic stroke volume has 
been validated,58 and the mitral regurgitant volume can be calculated as the difference.59 
By 3D color Doppler, it was first demonstrated that the direct measurement of VCA 
was feasible and showed better correlation with angiographic grading than the VCW.60 Later 
studies validated VCA against different 2D Doppler methods to calculate the ERO area 
(PISA, quantitative Doppler, VCW),55, 61-63 and regurgitant volume by MRI.64, 65 Either the 
apical or parasternal windows were used for pyramidal full-volume acquisitions made from 7 
– 14 subvolumes.55, 61-63, 65 The 3D dataset was manually cropped by an image plane 
perpendicular to the jet direction and moved along the jet until the vena contracta was 
identified, as demonstrated in Figure 11. The volume with the largest vena contracta,61-63 the 
most relevant lesion size,64, 65 and the mid-systolic frame in secondary MR and late-systolic 
frame in mitral valve prolapse, where the ERO area is usually the largest, were used.55 VCA 
was measured by direct planimetry, as a measure of ERO area, Eq. 12. 
. 12)	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Figure 11: 3D color Doppler acquisition of a mitral regurgitant jet; in 4-chamber view (left) and a cross-sectional view through the vena 
contracta demonstrating an asymmetric physiologic orifice or effective regurgitant orifice. Measurement of the VCA is performed by 
planimetry. 
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Little et al. demonstrated that the VCA correlated well with the shape and area of the 
orifice in vitro, while VCA was asymmetric in 89% of the cases in vivo.61 Kahlert et al. 
demonstrated that the shape of the VCA was noncircular and elongated along the commissural 
line in secondary MR due to leaflet tethering and incomplete mitral valve closure. In mitral 
valve prolapse, there was moderate asymmetry of the VCA, and in other degenerative 
diseases, the VCA was closer to a circular defect caused by a fixed lesion resulting from 
leaflet stiffening and thickening.55 Zeng et al. also demonstrated that the VCA was 
asymmetric in the majority of patients, regardless of etiology, but more elliptical and 
elongated in secondary MR than in primary MR.63 The ERO area by 2D PISA significantly 
underestimated the VCA in all patients, and to a greater degree in secondary MR.55, 63 VCA 
was feasible in both eccentric and central jets.62 In a recent study in patients with secondary 
MR and more than one MR jet, it was demonstrated that the vena contracta areas could simply 
be added together to approximate the total ERO area.66  
By multiplying the VCA by the VTI by CW Doppler, the regurgitant volume can be 
calculated, Eq. 13.64, 65 
. 13)	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1.2.5  Guidelines 
Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are the 
key examinations for evaluation of mechanism, etiology and feasibility of valve repair. 
Quantification of MR is based on 2D Doppler methods. Different 3D methods are evolving 
because of the limitations of 2D methods, but need further validation.  
In acute severe disease, surgery is indicated. In severe chronic primary MR, valve repair 
or replacement is indicated if there are symptoms, left ventricular dysfunction, pulmonary 
hypertension or atrial fibrillation, as they are predictors of events.33, 51, 52, 67-71 In  
asymptomatic severe chronic primary MR with preserved LV-function there is a 2a indication 
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for valve repair if there is a high probability of successful repair and low expected mortality.52 
In severe secondary MR, there is indication for mitral valve surgery when there is 
concomitant CABG.51, 52  
 
1.3 Aortic regurgitation 
1.3.1 Background 
In the Euro heart Survey on valvular disease, aortic regurgitation (AR) represented 13.3% of 
patients with single native left-sided disease.23  
The anatomy of the aortic valve is demonstrated in Figure 12, and dysfunction of any 
component of the aortic valve complex can cause incomplete coaptation and AR. 
 
 
Figure 12: Left: Parasternal long axis view of the aortic root; diameter at the annulus (red), Sinus Valsalva (blue) and sino-tubular junction 
(green). Right: Short axis of the aortic valve: right coronary cusp (RCC), non-coronary cusp (NCC) and left coronary cusp (LCC). 
 
In western countries, AR is most frequently caused by leaflet abnormalities such as a 
bicuspid valve or a degenerative, calcific valve disease. Other causes are aortic root dilatation 
secondary to hypertension or connective tissue diseases. In developing countries, rheumatic 
disease is the most prevalent cause of leaflet abnormalities and severe AR. Acute aortic 
regurgitation is caused by endocarditis and aortic dissection.  
NCC
RCC
LCC
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1.3.2 Hemodynamic consequences and outcome of aortic regurgitation 
In acute disease, there is an acute volume overload leading to reduced forward stroke volume 
and increased end-diastolic pressure. In chronic compensated disease, there is chronic volume 
overload and increased forward volume ejected into the aorta leading to a combination of 
eccentric and concentric hypertrophy and dilatation. Long-standing severe AR can cause 
irreversible myocardial damage. Measures of LV function are prognostic markers for 
outcome.51, 52, 72-74  
1.3.3 Assessment of severity of aortic regurgitation by 2D Doppler 
The severity of AR is evaluated by TTE and requires an integrated approach of 2D Doppler 
parameters.40, 75 Color Doppler imaging is sensitive to detect AR, but the jet area and length 
are not recommended for quantification due to weak correlation to severity of AR. The 
pressure half time (PHT) of the regurgitant jet by CW Doppler reflects the pressure difference 
between the aorta and the left ventricle. A PHT < 200 ms is consistent with severe AR, but the 
PHT is influenced by both aortic and chamber compliance as well as chamber pressures.76  
Holo-diastolic flow reversal of the upper descending aorta by PW Doppler and end-diastolic 
velocity of  > 18 cm/s is a sensitive sign of severe AR.77 However, reduced aortic compliance 
results in increased duration and velocity of the flow reversal. Both PHT of the regurgitant jet 
and diastolic flow reversal of the descending aorta are semi-quantitative parameters that are 
critically dependent on alignment of the Doppler beam and flow measurements.75  
Quantification is recommended, but the assessment of PISA is less extensively 
performed in AR compared with MR; however, when feasible, PISA is recommended to 
quantify the severity of AR.40, 75, 78 In addition to the assumption of hemispheric geometry, 
there are some additional limitations for aortic regurgitation such as interposition of valve 
tissue and difficulty in identifying PISA. There might also be obtuse flow convergence angles 
such as those with dilatation of the ascending aorta, perforation of a cusp or commissural 
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regurgitation. Quantitative Doppler is an alternative approach to quantifying AR, requiring 
several steps of calculations of stroke volumes, each having the potential for errors. An ERO 
area of 30 mm2 or a regurgitant volume > 60 mL indicate severe AR.40, 51, 52, 75 
The vena contracta is a direct measure of the ERO, and VCW correlates to the severity 
of AR.79, 80 It is recommended to measure the VCW in parasternal long axis and use the frame 
with the largest and most clearly defined vena contracta, as demonstrated in Figure 13 a. 
According to Guidelines, a VCW ≥ 6 mm is regarded as severe AR.40, 51, 52, 75   
1.3.4 Assessment of severity of aortic regurgitation by 3D Doppler 
VCW measurements might under- or overestimate AR severity because the vena contracta 
shape is not always circular. From 3D color Doppler imaging, we can measure the VCA 
without making geometric assumptions, and VCA has proven to be better than VCW 
measurements. This was first demonstrated by Fang et al.81 A cut-off value of VCA for severe 
AR, assessed by quantitative Doppler and aortography as a reference, was proposed at 50 
mm2.82 In a few studies VCA, was validated against MRI aortic phase contrast imaging.83, 84 
Either a parasternal or apical window were used for a full-volume acquisition of the aortic 
regurgitation made from 4 to 7 subvolumes. The dataset was cropped just downstream of the 
aortic valve in a plane perpendicular to the direction of the aortic regurgitant jet to identify the 
vena contracta as the narrowest part of the jet. The frame (volume) with the largest VCA,81 a 
mid-diastolic frame (volume) ,83 or the frame (volume) with the most relevant lesion size,84 or 
an unspecified frame(volume) were used.82 VCA was measured by direct planimetry in all 
studies, as a measure of ERO area, Eq. 12. 
To calculate regurgitant volume, VCA was multiplied by VTI of the mitral regurgitant 
jet by CW Doppler (MR VTI), Eq. 13.84 In Figure 13 b and c, measurements of the VTI by 
CW Doppler and direct measurement of the VCA by 3D color Doppler are demonstrated.   
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+  
Figure 13: 2D and 3D echocardiographic acquisition and analyses: a) The vena contracta width (red line) measured from the parasternal 
long axis, b) The velocity time integral (VTI) measured from the apical window in central jets, c) 3D color Doppler of the vena contracta and 
direct planimetry. 
VTI
A
B
C
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1.3.5 Guidelines 
 TTE and TEE are key examinations for evaluation of the mechanism, etiology and feasibility 
of valve repair. In the current guidelines, quantification of AR is recommended, based on 2D 
Doppler methods. With 3D color Doppler, a VCA of 50 – 60 mm2 has been proposed to 
define severe AR, but this needs further validation.  
In acute severe AR, urgent surgical intervention is indicated. In chronic severe AR, 
valve replacement or repair is indicated in patients with either symptoms or LV-dysfunction 
or in patients undergoing CABG or surgery of the ascending aorta.51, 52 
 
1.4 MRI 
MRI is an accurate and reproducible technique for assessing both the left and right ventricular 
volumes.85-87 Left ventricular stroke volume is calculated as the difference between the end-
diastolic and systolic volume from short-axis ventricular image slices, as demonstrated in 
Figure 14. The accuracy of the left ventricular volumes is dependent on correct placement of 
the basal ventricular image slice, with correct differentiation of the atrium and ventricle, as 
well as correct endocardial contour placement during post processing.   
 
 
 
 
 
Figure 14: MRI for assessing the left ventricular volumes. Image Courtesy 
of Brage H. Amundsen. 
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By using phase-contrast imaging, flow can be directly quantified. This technique is 
based on the property of protons moving in a magnetic field causing phase shift, and the 
magnitude of this phase shift is proportional to their velocity. Velocity can be measured and is 
displayed in grey-scale images, as demonstrated in the left part of Figure 15. Flow is derived 
from through-plane velocity maps by integrating the velocity of each pixel and its area over 
time, as demonstrated in the right part of Figure 15. There is good accuracy of flow 
measurements in in vivo studies.88-90 However, in vivo validation studies are limited by the 
lack of a true gold standard for comparison. Further, flow measurements are dependent on a 
homogenous magnetic field. The frame rate of about 25 – 30 Hz can be a limitation for the 
measurement of fast-changing velocities. 
 
 
Figure 15: Left: Through-plane phase-contrast velocity mapping from one systolic frame from the ascending aorta. Right:  Aortic flow 
patterns from several systolic (red/yellow) and diastolic frames (blue/green). Image courtesy of Brage H. Amundsen.  
  
In most cases, Doppler echocardiography provides the data needed for evaluation of 
valvular disease. MRI is indicated in patients with chronic primary MR or chronic AR to 
assess ventricular volumes, EF or severity of the regurgitation when these issues are not 
adequately addressed by TTE or TEE. Outcome data using MRI volumes is, however, 
lacking.51, 52 MRI is not as widely available as Doppler echocardiography, as MRI is more 
time-consuming, expensive and, most importantly, there are some contraindications.  
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1.4.1 MRI in mitral regurgitation 
Mitral regurgitant volume can be obtained by various methods, and is usually performed 
indirectly. The mitral regurgitant volume can be calculated as the difference between the left 
ventricular stroke volume from short-axis image slices of the left ventricle and the aortic 
stroke volume by phase-contrast measurement in the ascending aorta, Eq. 14.91 This relies on 
a combination of two different MRI techniques and increases the measurement errors. 
Alternatively, the difference between the left and right ventricular stroke volume can also 
calculate the mitral regurgitant volume, Eq. 15.92 This assumes the absence of an intra-cardiac 
shunt or another valvular regurgitation to be valid as well as accurate contour placement for 
volumetric assessment. Alternatively, using the difference between phase-contrast 
measurements from the mitral inflow and ascending aorta, the mitral regurgitant volume can 
be calculated, Eq. 16.93 By using phase-contrast measurements at the level of the mitral valve, 
the mitral regurgitant volume can be measured directly from the retrograde flow.94 Phase- 
contrast measurements at the mitral annulus are difficult due to the highly mobile mitral 
valve.  
. 14)	Q1./+	.04. ,+=>0 = 	R	,+=>0.5	&	 − 	$C	,		/,.1	& 
 
. 15)	Q1./+	.04. ,+=>0 = R	,+=>0.1	&	 − 	,+=>0.1	& 
 
. 16)	Q1./+	.04. ,+=>0 = 	$C	,		>1./+	13	+,-	,+=>0	 − $C	,		/,.1	& 
   
1.4.2 MRI in aortic regurgitation   
MRI has been validated in several studies in AR.88, 95-101 It is most common to assess AR by 
using aortic phase-contrast, measuring forward and regurgitant flow in the ascending aorta by 
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placing the imaging slice just above the aortic valve, and thus directly quantitating regurgitant 
volume from the regurgitant flow during one cardiac cycle and regurgitant fraction from the 
ratio between regurgitant and forward (systolic) volume, Eq. 17.88, 98, 100, 101   
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1.5 Multibeam HPRF color Doppler (MULDO) 
In laminar flow such as in the vena contracta, the backscattered Doppler power is proportional 
to the volume of blood in a sample volume of an ultrasound beam.102 The attenuation 
compensated volume flowmeter to measure volume flow in arteries was introduced by 
Hottinger and Meindl.103 Buck et al. hypothesized that this principle could be applied at the 
vena contracta, and that the total backscattered Doppler power (power integral) was 
proportional to the cross-sectional area of the vena contracta. They calculated volume flow 
through the vena contracta from the power-velocity integral and the regurgitant volume from 
the power-velocity-time integral and finally calculated mean VCA, by means of a single wide 
measurement beam and a narrow beam for calibration; Broad-beam spectral Doppler.104, 105  
We have extended this principle to using multiple narrow ultrasound beams covering 
the vena contracta region as well as using HPRF to be able to isolate the high-velocity 
Doppler signals in the vena contracta. HPRF is demonstrated in the left part of  Figure 16 and 
multiple beams in Figure 17. With HPRF, several pulses are fired before the deep echoes from 
the first pulses have returned to the probe, such that exact range information is lost in 
exchange for increased velocity span. We used a 3D color Doppler mode, with PRF typically 
being about 20 kHz and a transmitted frequency of 2.1 MHz, resulting in a Nyquist limit of 
about 3 m/s; a 3D HPRF color Doppler flow of the vena contracta is demonstrated in the right 
part of Figure 16. We used a clutter-filter with a cut-off frequency corresponding to 1.5 m/s to 
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remove the signals from the “spurious” sample volumes outside the jet. This acquisition uses 
a packet-size of 8 in each direction, and thus enables a reasonable volume rate of about 7 Hz. 
 
 
Figure 16: This picture is from an in-vitro model of a regurgitant jet as demonstrated by a 2D triplex-scan (left). HPRF increased the 
Nyquist limit and was implemented for 3D color Doppler (right) to isolate the vena contracta. Image Courtesy of Torbjørn Hergum. 
 
There were several narrow ultrasound beams (black), as shown in figure 17 a, covering 
the vena contracta region, and a composite measurement beam (blue) was made by summing 
the contribution from all beams. The region of interest (ROI) must be short radially 
(elevation) to enable HPRF. A wide single measurement beam (green), as used by Buck et al., 
is included for comparison. Our approach, multibeam HPRF color Doppler (MULDO), will 
ensure a more homogenous sensitivity of the measurement beam and higher signal-to-noise 
ratio compared with a single wide measurement beam (Figure 17 b). 
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Figure 17: a) Cross-sectional view through the vena contracta region. The reference beam (red), the beam with most Doppler power, is 
selected automatically as this beam is most likely to be within the jet of the vena contracta. A composite measurement beam (blue) is made by 
adding multiple narrow beams (black) together. b) In this sketch, nine narrow beams have been added to make a wide flat beam or a 
composite measurement beam (blue). The green line shows the beam profile of a single wide measurement beam from a smaller transducer. 
The peak sensitivity of this beam is about 8 dB lower than for the composite measurement beam (blue), and the sensitivity varies 
significantly. Picture from JASE, 2010; 23(1):1 – 8, reprinted with permission.  
 
As the flow through the vena contracta is laminar, the Doppler power of the composite 
measurement beam is proportional to the blood volume within the sample volume, and for a 
thin disk-like sample volume the Doppler power (Pmeas) will be proportional to the cross-
sectional area of the vena contracta. To get a calibrated Doppler power measurement, a 
reference beam (red) was chosen as the beam with the greatest Doppler power (Pref) because 
this beam was most likely within the regurgitant jet. A computer model provides the cross-
sectional area (Aref) of the reference beam and the constant, k. The VCA was proportional to 
the calibrated Doppler power, and therefore independent of attenuation or display parameters 
such as gain or tissue priority, and found by solving Eq. 18: 
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2 Aims 
2.1 General aims 
The main objective was to determine the accuracy of a new Doppler method, MULDO, for 
the quantification of valvular regurgitation. The evaluation was focused on to what extent this 
new method could produce more accurate information than current Doppler methods. 
 
2.2 Specific aims 
1) To study and validate MULDO in an in vitro model. 
2) To study and validate MULDO in patients with mitral regurgitation, and compare it 
with conventional Doppler methods, echo grading based on an integrated approach 
and MRI. 
3) To study and validate MULDO in patients with aortic regurgitation, and compare it 
with conventional Doppler methods, echo grading based on an integrated approach, 
3D color Doppler of the vena contracta and MRI. 
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3 Materials 
Study 1: This was a simulation study as well as an in vitro study using a pulsatile flow 
phantom and 6 prosthetic porcine valves with precisely cut circular holes varying from less 
than 10 to 40 mm2 to provide varying degrees of regurgitation performed at the Department of 
Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and 
Technology (NTNU), Trondheim, Norway, and at the Institute of Medicine, University of 
Bergen, Bergen, Norway. A few patients (N = 8) with moderate to severe MR at the 
Department of Cardiology, St Olav`s University Hospital in Trondheim, Norway, from 
October 2007 until February 2008 were studied in order to identify technical adjustments 
necessary prior to a larger in vivo testing of the method. This was a simplified protocol 
(without MRI) of the one approved by the Regional Committee for Medical and Health 
Research Ethics (REK, Midt-Norge) for study 2.   
 
Study 2: This study was performed at the Department of Cardiology, St. Olav`s University 
Hospital in Trondheim, the Department of Medicine, St Olav`s University Hospital in Orkdal, 
Norway, and at the Department of Circulation and Medical Imaging, Faculty of Medicine, 
Norwegian University of Science and Technology (NTNU), Trondheim, Norway, from March 
2008 until March 2009. The inclusion criteria were adult patients, who were followed on a 
regular outpatient basis, with mild to severe chronic MR of any etiology in sinus rhythm. 
Exclusion criteria were AR, cardiac arrhythmias and contraindications to MRI. We sought 
participants from the outpatient registry from the previous year`s consultations with MR as 
the main diagnosis and selected those without exclusion criteria for invitation to participate. 
The patient information and letter of invitation is in the Appendix; we sent requests to 71 
patients. Thirty-five patients with mild to severe MR consented to participate. Three 
participants were excluded because of poor MULDO acquisition and quality due to 
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misalignment of the Doppler beam and jet direction, difficulty in in identifying the vena 
contracta and incorrect positioning of the region of interest (ROI). In cases of exclusion due to 
poor MULDO quality, there were no jet signals above the noise level in the systolic frames 
during acquisitions over several heart beats, resulting in inability to measure the VCA. Four 
participants were excluded because of poor MRI quality caused by arrhythmias, and 1 
participant was excluded because of the requirement of hemodialysis between the 
investigations. There were 27 participants included in the analysis of the study. There were 11 
women and 16 men with a median age of 51 (range 28 – 81) years. In 11 participants, there 
was secondary (functional) MR, while the remaining participants had primary (organic) MR. 
Eccentric jets were present in 10 participants with primary MR and in 4 participants with 
secondary MR. The median EF was 50 (range 23 – 65)%. 
The study was approved by the Regional Committee for Medical and Health Research Ethics 
(REK, Midt-Norge) and the Norwegian Social Science Data Service.  
  
Study 3: This study was performed at the Department of Cardiology, St Olav`s University 
Hospital in Trondheim, the Department of Medicine, St Olav`s University Hospital in Orkdal, 
Norway, and at the Department of Circulation and Medical Imaging, Faculty of Medicine, 
Norwegian University of Science and Technology (NTNU), Trondheim, Norway, from 
December 2009 until February 2012. The inclusion criteria were adult patients, followed on a 
regular outpatient basis, with mild to severe chronic AR of any etiology in sinus rhythm. 
Exclusion criteria were cardiac arrhythmias, concomitant aortic stenosis or any 
contraindication to MRI. We sought participants from the outpatient registry at St Olav`s 
University Hospital in Trondheim and Orkdal from the previous year`s consultations with AR 
as the main diagnosis and selected those without exclusion criteria for invitation to 
participate. The patient information and letter of invitation is shown in the Appendix; we sent 
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requests to 60 patients. Twenty-nine of these patients consented to participate. Another 7 
patients with AR at the Department of Cardiology, Oslo University Hospital, Rikshospitalet, 
Norway, participating in another study fulfilling our inclusion criteria consented to participate 
in the MULDO study; being performed at Rikshospitalet from April 2011 until September 
2011. Finally, there were 36 patients participating. Due to poor MULDO acquisition and 
quality because of misalignment of the Doppler beam and jet direction, difficulty in 
identifying the vena contracta and incorrect positioning of the region of interest (ROI), we 
were not able to measure the VCA in 7 participants. In these cases, there were no jet signals 
above the noise level in the diastolic frames during acquisitions over several heart beats, and 
they were excluded from the analyses. There were 29 participants included in the analyses. 
There were 7 women and 22 men with a median age of 58 (range 18 – 83) years. The etiology 
was degenerative valve disease in 9, bicuspid aortic valve in 7, cusp prolapses in 3, aortic root 
disease in 6 and unknown in 4 participants. In 16 participants, there were eccentric jets and 
central jets in 13. The median EF was 60 (range 30 – 71)%. The median LVEDd was 61 
(range 45 – 72) mm, and the median LVESd was 39 (range 25 – 52) mm. The study was 
approved by the Regional Committee for Medical and Health Research Ethics (REK, Midt-
Norge). 
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4 Methods  
4.1 Study design 
Study 1: MULDO was tested in a simulation model and an in vitro model with a pulsatile 
flow phantom and porcine valves with orifices of known sizes (circular defects from less than 
10 to 40 mm2). The flow phantom was filled with blood-mimicking fluid, and the porcine 
valves were inserted into the flow phantom to provide various regurgitation severities. Several 
MULDO recordings were performed for each orifice size, both with stationary and pulsatile 
flow, performed and analyzed by Torbjørn Hergum.  
To obtain HPRF, the ROI had to be small in the radial direction; at the same time, 
there were clinical pilot trials in patients with MR performed by Thomas R. Skaug and 
Torbjørn Hergum to define the needs for this this method to work in a clinical setting. The 
azimuthal and elevation dimensions of the ROI should be large enough to measure any mitral 
regurgitation. At an early phase we used a ROI with a small radial depth of a 2 mm, as 
demonstrated in the left part of Figure18. The ROI had to be small in the radial direction to 
obtain HPRF. This was, however, difficult to use in patients, and we did not manage to obtain 
representative Doppler data until the ROI was subsequently increased in the radial direction 
up to 8 mm without significant loss of velocity resolution, as demonstrated in the right part of 
Figure 18. 
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Figure 18: MULDO acquisition from patients from some early clinical pilot trials in patients with mitral regurgitation. The left part of the 
picture shows ROI (red arrow points at the ROI)) with a radial depth of a few millimeters, which was difficult to use in patients. The right 
part of the picture after some modification of the method shows ROI depth of 8 mm (red arrow points at the ROI). 
 
Study 2: A clinical feasibility and validation study in patients with MR. We performed 
MULDO and 2D TTE exams (Thomas R. Skaug) before an MRI exam (Brage H. Amundsen 
and Thomas R. Skaug). All analyses were performed off-line to assess severity of MR by 2D 
Doppler and PISA measurements, regurgitant volume by MRI and MULDO analyses. There 
were different observers for the different analyses (MRI by Brage H. Amundsen, 2D Doppler 
and PISA by Terje Skjærpe and MULDO analyses by Thomas R. Skaug). MULDO was 
analyzed semi-automatically, and we assessed inter-observer variability of the same sets of 
recordings by the two investigators (Thomas R. Skaug and Torbjørn Hergum). MULDO was 
compared with different reference methods (2D Doppler parameters and MRI) to assess 
correlation and agreement. 
 
Study 3: A clinical feasibility and validation study in patients with AR. MULDO, 2D and 3D 
TTE exams were performed (N = 25 by Thomas R. Skaug, N = 4 by Stig Urheim) before an 
MRI exam (N = 25 by Brage H. Amundsen and Thomas R. Skaug, N = 4 performed at Oslo 
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University Hospital, Rikshospitalet) on the same day. All analyses were performed off-line to 
assess the severity of AR by 2D Doppler by an integrated approach, measuring VCW and VTI 
by CW Doppler, manual planimetry of VCA by 3D color Doppler and regurgitant volume and 
fraction by MRI and MULDO analyses. There were different observers for the different 
analyses (MRI by Brage H. Amundsen, 2D Doppler by Bjørn Olav Haugen (N = 25) or by 
Stig Urheim (N = 4) and 3D color Doppler analyses by Thomas R. Skaug). The MULDO 
recordings were validated by Torbjørn Hergum and/or Thomas R. Skaug before fully-
automatic MULDO analyses. MULDO was compared with different reference methods (2D 
Doppler, 3D color Doppler, MRI) to assess correlation and agreement. 
The MULDO recordings were analyzed semi-automatically in the first 20 participants 
by Thomas R. Skaug and Torbjørn Hergum to assess agreement between the semi-automatic 
and fully automatic measurements. 
 
4.2 Echocardiography acquisition and analyses 
In studies 1 and 2, all the participants were examined with a Vivid 7 scanner (GE Vingmed, 
Horten, Norway) with a phased-array (M3S) probe for the 2D recordings. In study 3, 25 
participants were examined with a Vivid 7 scanner with a M3S probe for the 2D recordings 
and a matrix array (3V) transducer for the 3D recordings, while in 4 participants an E9 
scanner was used with a phased array (M4S) and a 3V probe, respectively. 
  
Study 2: A standard 2D TTE examination was performed to assess the left ventricular 
function and evaluate the valvular lesions. We used PW-Doppler to measure the mitral and 
pulmonary flow as well as the flow in LVOT. A color Doppler acquisition was used to 
visualize the PISA, the vena contracta and the regurgitant jet from the parasternal long axis 
view as well as from apical 4 chamber, 2 chamber and long axis views. The Nyquist limit was 
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lowered, such that a flow convergence as close as possible to a hemisphere was shown in an 
apical view. The VTI and the peak regurgitant jet velocity were measured using CW Doppler. 
The mitral regurgitant flow rate by PISA was measured at the time of the peak regurgitant jet 
velocity and the PISA ERO area and regurgitant volume was calculated by a hemispheric 
approach, as demonstrated in Figure 8 and Eq. 5 - 8. We performed an integrated MR grading 
as follows: 1 = mild; 2 = mild to moderate; 3 = moderate to severe; and 4 = severe, according 
to recommendations.40  
 
Study 3: A standard 2D TTE examination was performed to evaluate the left ventricular 
function and evaluate the valvular lesions. We used CW Doppler from the parasternal long 
axis in eccentric jets and also from the apical five-chamber view in central jets to get the best 
possible alignment of the ultrasound beam and the regurgitant jet to measure the VTI and 
pressure half-time of the regurgitant aortic jet. Assessment of diastolic flow reversal in the 
descending aorta by PW Doppler was performed. A color Doppler acquisition was performed 
from both the parasternal long axis view and apical five-chamber view to visualize the vena 
contracta using a Nyquist limit of about 60 cm/s. The frame with the largest diameter of the 
vena contracta was selected to measure the VCW. Based on an integrated approach, AR 
severity was graded as: 1 = mild; 2 = moderate; and 3 = severe, according to recent 
recommendations.75 A 3D color Doppler examination was performed from the parasternal 
long-axis view. Full-volume of the flow data was acquired from six consecutive cardiac 
cycles, and the volume rate was about 15 volumes per second. The Nyquist limit was about 60 
cm/s, and we used a default clutter filter with a cut-off frequency corresponding to 20 cm/s. 
The dataset was cropped just downstream from the aortic valve in a plane perpendicular to the 
aortic regurgitant jet to find the vena contracta. The volume (frame) with the largest area of 
the vena contracta was chosen and measured by planimetry. Regurgitant volume was 
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calculated as: VCA • VTI measured separately by CW Doppler. 2D and 3D acquisitions and 
analysis are demonstrated in Figure 13.   
 
4.3 MRI acquisition and analyses 
In study 2 and 3, all patients were examined during supine rest using a Siemens Avanto 1.5-T 
system with a body matrix coil (Siemens, Erlangen, Germany). True fast imaging with steady-
state precession cine images were acquired during end-expiratory breath holds in 4-chamber, 
2-chamber and short axis from the base to the apex of the left ventricle. Steady-state free 
precession phase-contrast sequences were acquired during breath hold for flow quantification 
in the ascending aorta at the level of the right pulmonary artery. The encoding velocity was 
adjusted to just above maximal systolic velocity. The images were aligned perpendicular to 
the vessel wall. All images were analyzed using Segment.106 The MRI settings for acquisition 
of left ventricular volumes and aortic flow are shown in Table 1.  
    
Settings LV-acquisition Aortic Flow acquisition  
Retrospective ECG gating Yes Yes  
Typical in plane resolution 0.9 x 0.9 mm 1.3 x 1.3 mm  
Typical echo time 1.12 ms 3.09 ms  
Typical repetition time 58 ms 61.05 ms  
Slice thickness 6 mm 6 mm  
Slice gap 4 mm   
Frame rate  25 – 30 Hz 25 – 30 Hz  
Table 1.  
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Study 2: The left ventricular stroke volume was calculated semi-automatically drawing 
endocardial contours in short-axis images in end-diastole and end-systole (aortic valve 
closure). Systolic long-axis excursion was quantified by measuring the descent of the septal, 
lateral, inferior and anterior points of the mitral annulus in the 4- and 2-chamber views. The 
average value was incorporated into the stroke volume estimate in the software. Systolic flow 
in the ascending aorta was quantified from the phase-contrast images by drawing a ROI in the 
ascending aorta. The mitral regurgitant volume was quantified as the difference between the 
left ventricular stroke volume and the aortic stroke volume, Eq. 14.91  
The accuracy of this method was tested in an in vivo validation study in which the 
same measurements as those described above were taken in 9 subjects (4 healthy and 5 with 
recent myocardial infarction) in whom the absence of MR was confirmed by 
echocardiography. The estimated error was 3 ± 5 mL/stroke. 
  
Study 3: Systolic and diastolic flow in the ascending aorta was quantified from the phase-
contrast images by drawing an ROI in the reconstructed magnitude images. The aortic 
regurgitant volume was calculated from the diastolic retrograde flow, and the regurgitant 
fraction was calculated by dividing the regurgitant volume with the forward volume during 
systole, Eq. 17. This approach will slightly overestimate the regurgitant volume, as coronary 
flow during diastole will be included. We sought to reduce phase-offset errors in the velocity 
measurements by positioning the phase-contrast image in the isocenter, and using as low 
encoding velocity as possible.107 
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4.4 MULDO acquisition and analyses 
We used a Vivid 7 scanner (GE Vingmed, Horten, Norway) with a matrix array (3V) 
transducer in studies 1, 2 and 3 except for 4 participants in study 3, who were examined by an 
E9 scanner and a 3V transducer.  
 
Study 1: There were Doppler simulations to investigate the reference beam and the estimated 
VCA. In the in vitro study, the data acquisition was performed in two steps to ensure that the 
vena contracta was within the sample volume. First, the vena contracta was found by using a 
triplex scan (B-mode, HPRF PW Doppler and color Doppler) searching for the region with a 
high velocity, low spectral bandwidth and high power, as demonstrated in the left part of 
Figure 14, and subsequently switched to a 3D HPRF Doppler mode. The transmit frequency 
and the PRF were chosen with a reasonable tradeoff. A high PRF and low transmit frequency 
were required to obtain a high Nyquist limit. On the other hand, a high transmit frequency 
was desirable to increase the spatial resolution. The ultrasound settings are shown in Table 2. 
The 3D data were clutter filtered and analyzed off-line with Math lab (The Math Works, 
Natick, MA) to find the VCA from the calibrated Doppler power (Eq. 18). In the clinical pilot 
testing, MULDO recordings were acquired from the apical view in two steps and analyzed in 
a similar way as described for the in vitro study. 
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Ultrasound parameter Value 
Center frequency 2.1 MHz 
Pulse length 5.5 periods 
PRF 21 KHz 
ROI (azimuth x elevation x radial) 19.2 x 18.0 x 8 mm 
Volume rate 7 Hz 
Focal depth 8.9 cm 
Packet size 8 
Table 2 
 
Study 2: The MULDO recordings were acquired from the apical view in two steps, similar to 
the in vitro study. With the scanner in a triplex mode, the vena contracta was located by 
moving the pulsed-wave sample volume into the jet flow shown by color Doppler imaging 
and adjusted to include the highest velocities with a low/narrow spectral bandwidth. The 
scanner was then switched to multibeam HPRF color Doppler mode, with the position of the 
3D ROI centered on the pulsed-wave sample volume, as demonstrated in Figure 19. 
 The depth of the ROI was about 9 – 10 cm, and the ultrasound parameters are 
demonstrated in Table 2. We obtained a Nyquist limit of about 3 m/s, so that a jet flow of 
about 6 m/s could be resolved. Each recording consisted of about 10 – 15 heart cycles of real-
time 3D data with a volume rate of about 7 – 10 Hz. 
  
40 
 
 
Figure 19: Two-step acquisition using a triplex-scan (left part of the figure) to localize the vena contracta before switching to multibeam 
HPRF color Doppler mode (right part of the figure). Picture is modified from JASE 2010, reprinted with permission. 
 
Cross-sectional images of multibeam HPRF color Doppler flow of the vena contracta 
could be visualized, as demonstrated in Figure 20. 
 
 
Figure 20: Cross-sectional image of multibeam HPRF color Doppler flow of the vena contracta from one systolic frame.  
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The raw 3D Doppler data were analyzed semi-automatically to find the VCA using 
custom software (GC mat). Frames corresponding to systole were selected manually by the 
observer, and some frames were excluded by the observer according to the following criteria: 
• There was no visible jet above the noise level 
• The ROI did not cover the jet area 
• The vena contracta was not within the ROI. 
The output was cross-sectional Doppler power images of the vena contracta, as 
demonstrated in two of the frames in Figure 21, and calibrated Doppler power measurements 
and estimates of the VCA from all of the selected systolic frames, Eq. 18. We chose the 
median value of the measurements as an estimate of the VCA.  
To assess inter-observer variability of the MULDO analyses, another blinded observer 
randomly analyzed 18 of the subjects. The regurgitant volume was calculated as the product 
of VCA and the VTI of the regurgitant jet, measured separately by CW Doppler. 
 
 
 
Figure 21: Cross-sectional Doppler power images of the vena contracta from two systolic frames in mitral regurgitation. Note that there is a 
visible jet and that the vena contracta was within the ROI. The third frame was excluded as there was no jet signal above the background 
noise level. 
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Study 3: MULDO recordings were acquired from the apical 5-chamber view for central jets 
and from the parasternal long axis or eccentric jets to get the best possible alignment of the 
ultrasound beam and the aortic regurgitant jet. The vena contracta was found by using a 
triplex mode and then switched to the multibeam HPRF color Doppler mode in a similar way 
as described under study 2. Acquisitions from the parasternal long axis and from the apical 5-
chamber views are shown in Figure 22. 
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Figure 22: Two step acquisition (left: triplex mode and right: multibeam HPRF color Doppler acquisition) from the parasternal long-axis 
view (upper) in an eccentric aortic regurgitation with jet direction towards the anterior mitral leaflet and from the apical 5-chamber view 
(lower) in a central aortic regurgitation. Picture is modified from EHJ-CI 2014 and reprinted with permission. 
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The ROI was typically at a depth of 5 – 12 cm, depending on the apical or parasternal 
window. The ultrasound parameters were not different from those described in study 1 and 2. 
The Nyquist limit was about 3 m/s. A recording consisted of 10 – 15 heartbeats of real-time 
3D data with a volume rate of about 7 – 10 Hz. Cross-sectional images of multibeam HPRF 
color Doppler flow of the vena contracta could be visualized, as demonstrated in Figure 23. 
  
 
Figure 23: In the left part of the figure cross-sectional images of multibeam HPRF color Doppler flow of the vena contracta acquired from 
the parasternal long axis, and in the right part of the figure are those acquired from the apical 5-chamber view, in two subjects with aortic 
regurgitation.  
 
  The raw 3D Doppler data were analyzed fully automatically using Math lab (The Math 
Works, Natick, MA). All of the diastolic frames during a recording were automatically found 
by the software. The output was cross-sectional Doppler power images of the vena contracta, 
as demonstrated in Figure 24, and the calibrated Doppler power measurements and estimate 
of the VCA from all diastolic frames. The median value of all measurements was chosen as an 
estimate of the VCA.   
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Figure 24: Cross-sectional Doppler power images of the vena contracta from three diastolic frames in aortic regurgitation. 
 
All recordings in 29 patients were validated by an observer to assure that the cross-
sectional Doppler power images displayed a jet above the noise level and that the vena 
contracta was within ROI, as demonstrated in Figure 24; however, there was no need for 
manual interactions to calculate the VCA. To assess repeatability, a separate and repeated 
recording from the same subject was similarly analyzed. The regurgitant volume was 
calculated as the product of VCA and VTI of the regurgitant jet, measured separately by CW 
Doppler.  
 
Fully automatic vs semi-automatic analysis of MULDO (not published data): In the first 
20 patients with AR in study 3, the same MULDO data was assessed by two observers to 
estimate VCA semi-automatically, as described in study 2, in addition to fully automatically, 
as described in study 3, to assess agreement between the fully automatic and semiautomatic 
measurements.  
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4.5 Statistics 
For both study 2 and 3 descriptive values were reported as median and range, and Spearman`s 
rank correlation was used because the continuous variables were not normally distributed. 
Because the differences were normally distributed, we used paired sample t test to compare 
the regurgitant volume and VCA by different methods, being reported as mean (95% 
confidence interval). The agreement between the continuous variables was assessed by 
calculating the 95% limits of agreement (mean difference ± 2 SD). To assess agreement 
between different or categorical variables, we used κ (kappa) statistics. Inter-observer 
variability and repeatability were assessed as the coefficient of repeatability, defined as 2 SD 
of the differences. The statistical analyses were performed using SPSS (SPSS, Inc., Chicago, 
IL, USA). 
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5 Summary of results 
Study 1: Simulation results demonstrated that the Doppler power estimate of the reference 
beam was increasingly overestimated with an increasing number of beams within the orifice 
and thus the orifice size. With less than 10 beams within an orifice, the reference beam will be 
overestimated by up to 20%, resulting in underestimation of the vena contracta area. In vitro, 
the estimated vena contracta area and true areas of several orifices were investigated using 
both stationary and pulsatile flow in the flow phantom, and the results followed the same 
trend as the simulated results. There was a slight overestimation of the small areas and 
underestimation of the larger areas. These simulation and in vitro results are shown in Figure 
8 of this paper. The results from the pilot clinical testing of 5 patients with MR were 
presented at Euro Echo 2008 with PISA for comparison (see Appendix).108  
Study 2: In 3 of the 35 participants, MULDO was not feasible and another 5 participants were 
excluded for other reasons described in the Materials section. This study showed that this 
method was feasible in MR. The 95% limits of agreement between MRI and MULDO 
regurgitant volume (N = 27) were −3.0 ± 26.2 mL. We were not able to measure PISA in 5 of 
the 27 participants. Omitting the 5 participants in whom we were not able to measure PISA, 
the 95% limits of agreement between MRI and PISA regurgitant volume (N = 22) were 4.7 ± 
30.6 mL. The agreement between echocardiographic MR grade and regurgitant volume 
measured by MRI and MULDO is demonstrated in Figure 25. Inter-observer analysis of 
MULDO VCA in 18 participants demonstrated a coefficient of repeatability of 8.7 mm2 and a 
corresponding coefficient of repeatability for MULDO regurgitant volume of 9.8 mL. 
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Figure 25: Kappa agreement between echocardiographic MR grade and MULDO regurgitant volume and between echocardiographic MR 
grade and MRI regurgitant volume were 0.44 and 0.48, respectively. There were four echocardiographic MR grades based on severity 
(1=mild, 2=mild to moderate, 3=moderate to severe, 4=severe) and four categories of regurgitant volume (<30 mL, 30 to 44 mL, 45 to 59 
mL and ≥ 60 mL) used to assess agreement. Figure from JASE 2010; reprinted with permission. 
 
Study 3: In 7 of the 36 participants, MULDO data were not representative. In the remaining 
29 participants, MULDO was feasible. The 95% limits of agreement between regurgitant 
volume by MRI and MULDO and between MRI and 3D color Doppler were −14.4 ± 29.1 mL 
and −47.8 ± 60.9 mL, respectively. The agreement between echocardiographic AR grade and 
VCA by MULDO and 3D color Doppler, respectively, is demonstrated in Figure 26. The 
analysis of MULDO VCA was made fully automatically; consequently, there was no inter- or 
intra-observer variability. In a separate recording from the same participant, the coefficient of 
repeatability for MULDO VCA estimates was 9.4 mm2. 
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Figure 26: Kappa agreement between echocardiographic AR grade and MULDO VCA and between AR grade and 3D CFI VCA was 0.50 
and 0.64, respectively. Figure from EHJ-CI 2014; reprinted with permission. 
 
Fully automatic vs. semiautomatic analyses (Unpublished data): The 95% limits of 
agreement between fully automatic VCA vs. semi-automatic VCA by observer 1 and observer 
2, respectively, in 20 participants with AR were 0.6 ± 3.0 mm2 and 0.5 ± 4.2 mm2, 
respectively (Figure 27 a and b). The 95% limits of agreement between semi-automatic VCA 
by observer 2 and observer 1 in 20 participants with AR were -0.1 ± 3.4 mm2 (Figure 27 c).  
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Figure 27: a) and b) 95% limits of agreement between fully automatic and semiautomatic VCA estimate between two observers, c) and 95% 
limits of agreement between semiautomatic VCA between two observers. Unpublished data.    
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6 Discussion 
6.1 Main findings/feasibility 
A 3D echo Doppler method, multibeam HPRF color Doppler (MULDO), was developed for 
the quantification of valvular regurgitation, and was validated in vitro and in vivo. In study 1, 
simulation and in vitro results were presented, and it was demonstrated that the vena contracta 
area (VCA) could be quantified for various orifice sizes from less than 10 to 40 mm2 
corresponding to mild to severe regurgitation. In simulation and in vitro the VCA was 
overestimated when the orifices were small and the reference beam was not entirely within 
the orifice. For larger orifices with several potential reference beams within the orifice the 
power of the reference beam was overestimated due to stochastic variation of the Doppler 
signals in simulation, and thus the estimate of the VCA was to some degree underestimated. 
However, the in vitro results were closer to the true values for larger orifices than the 
simulation results. In study 2, it was demonstrated that MULDO was feasible in both primary 
and secondary MR as well as in central and eccentric jets, except in 3 out of 35 participants. 
The severity of MR could be quantified using this method, and there was good agreement 
between MRI and multibeam HPRF color Doppler in moderate and severe MR, which was 
lower in mild MR. In study 3, it was demonstrated that MULDO was feasible in both central 
and eccentric AR jets regardless of etiology, except in 7 out of 36 participants. The severity of 
AR could be quantified by this method, and there was good agreement between MRI and 
multibeam HPRF color Doppler in moderate and severe AR, but relatively poor agreement in 
mild AR. VCA by MULDO was found semi-automatically in studies 1 and 2 and fully 
automatically in study 3, and VTI was found separately by CW Doppler.        
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6.2 Choice of reference methods 
In study 1, MULDO was validated against the true size of the orifices of porcine valves in a 
pulsatile flow phantom. In a clinical setting in studies 2 and 3, there was no similar gold 
standard to assess valvular regurgitation. In most cases Doppler echocardiography provides 
the data needed for clinical decision-making in valvular regurgitation based on the mechanism 
of regurgitation, an integrated echo grading of severity and evaluation of its hemodynamic 
consequences and ventricular function together with a clinical evaluation of symptoms. 
However, it may sometimes be difficult to assess the severity of a valvular regurgitation with 
a need for supplemental investigation by TEE or MRI.  
By MRI phase contrast imaging, the regurgitant jet can be visualized and measured 
using long-axis and short axis cines. Theoretically, the vena contracta could be measured, 
which would be an ideal comparison for MULDO. However, this method is not widely used 
and is subject to significant variability depending on acquisition parameters such as image 
slice thickness and frame rate, post-processing and experience of the user. It is therefore not 
recommended to measure the vena contracta by MRI.109, 110 On the other hand, flow 
measurements have been validated in vitro and in vivo using invasive measurements and 
Doppler measurements as a reference.89, 90 Left ventricular volumes can be calculated 
accurately using steady-state free precession sequences, but the accuracy of the left 
ventricular volumes is dependent on correct planimetry of short-axis ventricular image slices 
in both end-diastole and end-systole during post-processing to measure the left ventricular 
stroke volume.85-87  
There are different MRI techniques for MR quantification which have been validated 
in clinical trials by comparison with echocardiography and angiography, showing good 
correlation; however, a true gold standard is lacking.91-93, 97 In study 2, we used MRI to 
quantify mitral regurgitant volume, while MULDO estimated the VCA. By multiplying the 
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VCA with the VTI measured separately by CW Doppler, the regurgitant volume was 
calculated, making it comparable to MRI. Quantification of the mitral regurgitant volume by 
MRI is commonly performed indirectly by subtracting aortic systolic flow measured by phase 
contrast from the left ventricular stroke volume by volumetry.91 We tested the accuracy of this 
method (the difference between the left ventricular stroke volume and aortic systolic flow) in 
an in vivo validation in 9 subjects without valvular regurgitation, and the estimated error was 
3 ± 5 mL/stroke. Patients with concomitant AR have to be excluded to make this method valid 
for the quantification of mitral regurgitant volume. Alternatively, the mitral regurgitant 
volume could be calculated indirectly by comparing the difference in ventricular stroke 
volumes assuming the absence of intra-cardiac shunts and another valvular regurgitation. It 
also assumes correct planimetry for both ventricles in systole and diastole, which can be 
particularly difficult for the right ventricle.   
Further, we used 2D TTE to quantify regurgitant volume from PISA, and MR echo 
grading was divided into mild, moderate, moderate to severe and severe MR, corresponding 
to grades 1, 2, 3 and 4, according to the recommendations of an integrated approach.40 Some 
of the limitations of PISA were discussed in the section 1.2.3; this made the assumption that 
the geometry of the regurgitant orifice area was circular, but this method has demonstrated 
prognostic value in both primary and secondary MR.41, 42 The severity of valvular 
regurgitation is based on echo grading. PISA is not always feasible or valid for quantification, 
or the calculations may be erroneous, while echo grading is based on an integrated approach 
of quantitative, semi-quantitative and qualitative parameters, each of which has its strengths 
and limitations.39    
By using aortic phase-contrast imaging both the aortic regurgitant volume and fraction 
can be measured directly, and it has been validated in both in vitro and clinical studies. There 
is no true gold standard for the comparison of accuracy of aortic phase-contrast measurements 
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in vivo. However, the aortic regurgitant quantification using aortic phase-contrast imaging 
correlates well with angiographic grading and Doppler echocardiography, and has 
demonstrated excellent repeatability of measurements.88, 100, 101, 111 In study 3, MRI aortic 
phase contrast was used as a reference method to measure regurgitant volume.   
3D color Doppler has been validated in previous studies,81-84 and we measured the 
VCA by direct planimetry and compared it to VCA by MULDO in study 3. By multiplying 
VTI measured separately from CW Doppler and VCA measured by either MULDO or 3D 
color Doppler, we calculated the regurgitant volume by both methods to make it comparable 
to MRI regurgitant volume. We similarly used 2D TTE as another reference method, but 
PISA is less well validated and technically more difficult for AR than for MR. We measured 
the VCW from 2D Doppler, and AR echo grading was divided into mild, moderate and severe 
AR according to the latest recommendations.75 As there are no established cut-off values for 
MULDO, we used recommended ERO areas by 2D quantitative methods as cut off values to 
establish agreement between AR grade and MULDO. To assess agreement between AR echo 
grade and 3D color Doppler VCA, we used cut-off values of 30 and 50 mm2 for mild and 
severe AR, respectively, as proposed by Chin et al.82  
Further, agreement between MRI regurgitant fraction and MULDO could be of 
interest, but there are no consensus cut-off values of regurgitant fraction to define AR severity 
categories such as mild, moderate and severe. In a recent study, qualitative and semi-
quantitative echo Doppler parameters were used as a reference method to establish MRI cut-
off values with which to assess AR severity. The aortic phase-contrast regurgitant fraction 
cut-off value that best defined severe AR was ≥ 30 % at the Sino-tubular junction or mid-
ascending aorta, which should be noted as being different from the Doppler-based regurgitant 
fraction range criteria. They demonstrated that the positioning of the image slice of phase 
contrast flow measurements influences the measurements of regurgitant volume and fraction, 
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and that the regurgitant volume and fraction were significantly higher when measured at the 
Sino-tubular junction than at the distal ascending aorta.98 In another recent study, qualitative 
and semi-quantitative echo grading was as well used as a reference method to establish aortic 
phase-contrast cut-off values measured at the level of the pulmonary artery bifurcation, and a 
regurgitant fraction > 46% best defined severe AR. There are several possible explanations 
for these differences.97 About 40% of the patients in the study by Gabriel et al. had a 
congenitally deformed valve, which was associated with eccentric and turbulent flow through 
the ascending aorta, and may be one possible explanation for the differences in studies, since 
phase-contrast measurements rely on laminar flow. There is also a lack of data evaluating the 
accuracy of flow measurements in large aortic diameters.  
Outcome studies are sparse, except for a prospective study by Myerson et al. of 113 
asymptomatic patients which demonstrated that a regurgitant fraction > 33% was the optimal 
threshold for identifying patients with the development of symptoms and the need for valve 
replacement within a few years (sensitivity of 85% and specificity of 92%).112 Due to 
differences in various studies and no consensus, we did not categorize AR severity as mild, 
moderate and severe according to aortic phase-contrast regurgitant fraction values to establish 
agreement with MULDO or 3D color Doppler, even though the study by Myerson was 
interesting and defined a cut-off value with outcome data.     
     
6.3 Agreement  
6.3.1 Agreement between MRI and MULDO compared with other 2D and 
3D Doppler methods 
In study 2, there was good correlation between MRI and MULDO. There was a significant 
difference between these methods in those with mild MR, defined as MRI regurgitant volume 
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< 30 mL, but no significant difference in those with moderate to severe MR, defined as MRI 
regurgitant volume ≥ 30 mL. The 95% limits of agreement between these methods were quite 
wide (−3.0 ± 26.2 mL), which can be explained by the overestimation of mild MR by 
MULDO. Buck et al. demonstrated excellent agreement between the Broad-beam spectral 
Doppler method and MRI in patients with MR, reporting a mean difference of 0.4 mL and 1 
SD of 3.2 mL corresponding to 95% limits of agreement of 0.4 ± 6.4 mL.105  There are some 
differences to note. Our population was characterized by a wider range of regurgitant volume 
measured by MRI (4 – 129 mL) than in the population investigated by Buck et al. (6 – 46 
mL). We measured VCA from 12.0 to 59 mm2, regurgitant volume from 14.2 to 99.0 mL by 
MULDO. Buck et al. reported mean VCA from 11 to 61 mm2 and regurgitant volume from 
11.5 to 36.9 mL by the Broad-beam spectral Doppler method. Interestingly, the results from 
the individual participants are listed in Table 1 in the paper by Buck et al., which give some 
idea of the relationship between the mean VCA and the regurgitant volume by their method. 
In one of the participants with degenerative MR, the mean VCA and regurgitant volume was 
0.61 cm2 and 35.8 mL and in another participant 0.40 cm2 and 27.6 mL, respectively. In one 
of the participants with ischemic cardiomyopathy, the mean VCA and regurgitant volume was 
0.11 cm2 and 15.7 mL and in another they were 0.39 cm2 and 18.8 mL, respectively. It is 
worth noticing lower regurgitant volumes relative to VCA in the study by Buck et al. The 
regurgitant volume and the mean VCA were calculated directly from the same acquisition. 
We measured VCA by MULDO and VTI separately by CW Doppler, from 74 to 213 cm, to 
calculate the regurgitant volume. The VTI is dependent on the pressure difference between 
the left ventricle and left atrium, as well the duration of the regurgitant flow, which can 
explain discrepancies in VCA and regurgitant volume. Further, there can be dynamic 
variation of flow and ERO area. In the study by Buck et al., 63% of the participants had 
secondary MR, while 41% of the participants in our study had secondary MR; the remaining 
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37% and 59%, respectively, had primary MR. The calculation of MRI regurgitant volume was 
somewhat different, as we measured the left ventricular stroke volume by volumetric 
measurements of the left ventricle, while Buck et al. used phase-contrast measurements of the 
mitral inflow. We both used phase contrast to measure aortic stroke volume. The regurgitant 
volume was calculated as the difference between either the mitral inflow or left ventricular 
stroke volume and the aortic stroke volume. 
Marsan et al. used 3D color Doppler to measure the VCA and CW Doppler to measure 
the VTI to calculate the regurgitant volume in secondary (functional) MR, with MRI as a 
reference method. The 95% limits of agreement between 3D color Doppler and MRI were 
−0.08 ± 7.6 mL.65 They used the systolic frame with the most relevant lesion size to measure 
the VCA, and the phase-contrast measurement at the level of the mitral valve to calculate 
regurgitant volume directly. This was in contrast to our study using the indirect method (see 
Eq. 14), using volumetry of the left ventricle and aortic phase contrast. It is difficult to assess 
in what way these different MRI methods affect the agreement between the various methods, 
as the different MRI methods have their strengths and limitations. Mitral phase-contrast 
imaging can, however, be difficult in cases of excessive mitral annular movements which is 
not uncommon in primary MR in contradiction to secondary MR.    
More recently, Shanks et al. used 3D TEE color Doppler to measure the VCA and CW 
Doppler to measure the VTI to calculate regurgitant volume in patients with secondary 
(53.3%) and primary (46.7%) MR, with MRI as a reference method. The 95% limits of 
agreement between 3D TEE color Doppler and MRI were −2.3 ± 16.3 mL.64 They used the 
systolic frame with the most relevant lesion size to measure the VCA, and used the difference 
between volumetric measurements of the left ventricular stroke volume and aortic stroke 
volume by phase contrast to the measure regurgitant volume, similar to the method we used. 
One advantage of TEE is a shorter scan depth with higher volume rate, as well as better 
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visualization of the valve and improved resolution, which should improve the accuracy of 
measurements. In our study, PISA was feasible in 22 out of 27 participants, and we 
demonstrated wider 95% limits of agreement between MRI and PISA (4.7 ± 30.6 mL) than 
between MRI and MULDO (−5.1 ± 23.9 mL). We used PISA by 2D Doppler using the frame 
corresponding to the peak regurgitant jet velocity and a hemispheric approach. Shanks et al 
similarly demonstrated that 95% limits of agreement between PISA by 2D TEE and MRI was 
−12.4 ± 33.2 mL.64 The limits of agreement between MRI and PISA in the study by Shanks et 
al. and the current one were similarly wide, with both studies making an assumption of the 
PISA geometry by 2D color Doppler. 
In study 3, there was moderately good correlation between MRI and MULDO, but the 
regurgitant volume calculated from MULDO and CW Doppler overestimated the severity of 
AR compared with MRI; however, agreement was better for those with MRI regurgitant 
volume ≥ 30 mL compared with those with MRI regurgitant volume < 30 mL. The 95% limits 
of agreement between these methods were quite wide (−14.4 ± 29.1 mL). The regurgitant 
volume calculated from 3D color Doppler and CW Doppler significantly overestimated the 
severity compared with MRI, and the 95% limits of agreement between MRI and 3D color 
Doppler were wider (−47.8 ± 60.9 mL). In a recent study by Ewe et al., there was excellent 
agreement between MRI and 3D color Doppler.84 They similarly used aortic phase-contrast 
imaging as a reference method. There are some differences to note. We measured VTI from 
the apical window in central jets and from the parasternal window in eccentric jets, while Ewe 
et al. measured VTI from the apical window in both central and eccentric jets. If we were to 
measure VTI from the apical window in eccentric jets, we would underestimate the VTI 
compared with measurements from the parasternal window. This would result in a lower 
regurgitant volume by both MULDO and 3D color Doppler and less overestimation by these 
methods compared with MRI, and probably better agreement. We performed 3D color 
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Doppler acquisition from the parasternal window, while Ewe et al. used both the apical and 
parasternal window. With 3D color Doppler, we used the frame with the largest VCA, while 
Ewe et al. used the frame with “the most relevant lesion size”. If we used “a more relevant 
lesion size”, VCA by 3D color Doppler could possibly be lower than using the largest VCA, 
and the regurgitant volume would be lower with less overestimation compared with MRI. 
Finally, there were different scanners and probes, and there might be some differences 
regarding the spatial and temporal resolution.        
 
6.3.2 Agreement between 2D/3D Doppler echocardiography and MULDO 
In study 2, we demonstrated that PISA by the hemispheric approach was significantly lower 
than MULDO, both ERO area and regurgitant volume. The 95% limits of agreement were 
−0.08 ± 0.28 cm2 and −9.8 ± 37.0 mL. In 3D studies, it has been demonstrated that the PISA 
is hemielliptic rather than hemispheric because of asymmetric geometry of the regurgitant 
orifice area, especially in secondary MR. This results in significant underestimation of ERO 
area by a hemispheric PISA approach as compared with either a hemiellliptic PISA 
approach,53, 54 or VCA by 3D color Doppler.55, 63, 113 Kahlert et al. demonstrated that the 95% 
limits of agreement between ERO area measured by a hemispheric and hemielliptic approach 
were −0.2 ± 0.4 cm2, and the 95% limits of agreement between a hemispheric PISA approach 
and VCA was −0.09 ± 0.28 cm2. Comparing all methods, they used the mid-systolic frame in 
secondary and some of the primary MR, while they used the late-systolic frame in mitral 
valve prolapse where the ERO area is usually the largest.55   
There was moderately good agreement between echo MR grade and regurgitant 
volume assessed by MULDO (κ = 0.44). As MULDO overestimates mild regurgitation (MRI 
regurgitant volume < 30 mL), this can contribute to some of the overlap, especially between 
MR grade 1 and 2, as illustrated in Figure 25. Agreement was better for primary than 
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secondary MR between the various methods. This probably stems from the same source as the 
overestimation of mild MR. The regurgitant orifice is often asymmetric and noncircular in 
secondary MR, meaning that the cross-sectional area may be large, but still not able to 
encompass the full reference beam. Besides, those with primary MR were part of a higher 
regurgitant volume population than those with secondary MR.  
In study 3, we demonstrated reasonably good correlation between VCA measured by 
3D color Doppler and MULDO, but 3D color Doppler measurements were significantly 
higher than MULDO, which explains the difference in regurgitant volume by the two 3D 
methods in our study. There are several differences between these methods, which are further 
discussed under “Methodological differences”.  
We did not calculate the ERO area from 2D Doppler methods in study 3. In a recent 
study by Sato et al., they demonstrated good correlation and agreement between 2D VCA and 
3D VCA (r = 0.97 and 95% limits of agreement −0.36 ± 8.1 mm2). There was also good 
correlation and agreement between 2D VCA and ERO area by PISA (r = 0.89 and 95% limits 
of agreement 4 ± 14.2 mm2).114 PISA is challenging in AR, and it also makes assumptions of 
the geometry of the ERO area. We did not measure the VCA from 2D parasternal short axis 
views, as it is difficult to assure that the imaging plane is through the vena contracta and that 
the imaging plane is perpendicularly aligned to the jet direction, especially in eccentric jets, 
both of which result in overestimation of the VCA. 
Correlation and agreement between AR grade and VCA by MULDO were moderately 
good (rs = 0.76 and κ = 0.50). Chin et al. demonstrated good correlation between 3D color 
Doppler VCA and AR severity assessed by Doppler methods,82 and we similarly 
demonstrated moderately good correlation and agreement between AR grade and VCA by 3D 
color Doppler ( rs = 0.76 and κ = 0.64).  
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6.4 Methodological differences 
In both studies 2 and 3, MRI was a reference method calculating the regurgitant volume. In 
study 2, the mitral regurgitant volume was calculated as the difference between LV 
volumetric stroke volume and aortic phase contrast stroke volume. In study 3, the aortic 
regurgitant volume was calculated directly from the aortic phase contrast retrograde flow, and 
thus somewhat different from the mitral regurgitant volume in study 2.  
The VCA by MULDO was found semi-automatically in study 2 and fully 
automatically in study 3 from the calibrated Doppler power of the vena contracta, requiring no 
manual calculations, and we used the median value of VCA from frames/volumes over 
several heart beats. The VCA is a measure of the ERO area, and calculation of regurgitant 
volume requires the VTI measured separately by CW Doppler. 
In study 2, we used PISA, based on 2D color Doppler, making assumptions of a 
hemispheric geometry of the PISA and a circular regurgitant orifice, to calculate flow rate. 
We measured the flow rate by PISA at the time of maximal regurgitant jet velocity. An 
additional step was required to calculate the ERO area from this method, dividing PISA flow 
rate by the maximal velocity of the regurgitant jet by CW Doppler. Regurgitant volume was 
similarly calculated from the ERO area and VTI by CW Doppler. As discussed in section 
6.3.2, calculations of ERO area and regurgitant volume by the hemispheric PISA approach 
was significantly lower than VCA and regurgitant volume by MULDO. 
In study 3, we used VCA measured by 3D color Doppler as a reference method, and it 
was significantly higher than VCA by MULDO, which explains the differences in regurgitant 
volume, calculated as the product of VCA by both methods and VTI measured separately by 
CW Doppler.  
3D color Doppler and MULDO differ in several ways. Most importantly, the HPRF and 
clutter filter in the proposed method enabled the isolation of the high-velocity core of the vena 
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contracta, in contrast to regular color Doppler, which also measured low-velocity entrained 
blood. The clutter filter cut-off frequency corresponded to 1.5 m/s for multibeam HPRF color 
Doppler and 0.2 m/s for 3D color Doppler.  
Secondly, in 3D color Doppler, it was common to reduce the lateral resolution 
somewhat to gain some extra frame rate. The MULDO algorithm automatically compensated 
for the overestimation due to limited lateral resolution as long as the reference beam was 
within the vena contracta jet.  
Thirdly, altering the display parameters such as gain and tissue priority during 
acquisition did not affect the MULDO data. On the other hand, the 3D color Doppler was 
gain-dependent, and the width and area of a regurgitant orifice could be overestimated with 
approximately one beam width in each direction (azimuth and elevation).  
Furthermore, each recording of MULDO consisted of 10 to 15 heartbeats of real-time 
full-volume datasets, while 3D color Doppler datasets were reconstructed from several 
heartbeats of subvolumes to make a full volume, which can predispose to stitching artefacts 
and overestimation of the VCA.  
The measurements of the Doppler power in all the diastolic frames in a MULDO 
recording were fully automatic, and the median value of these measurements was chosen as 
the VCA. The 3D color Doppler dataset post-processing on the other hand consisted of 
sequential cropping of the regurgitant jet, manual tracing, and the volume (frame) with the 
largest area of the vena contracta was chosen, similarly to VCW.75  
Dynamic variation of the regurgitant orifice area could be another contributing factor 
for the differences in VCA measurements. Using the volume (frame) with the largest VCA in 
3D color Doppler, with a volume (frame) rate of ~ 15 volumes per second, and the median 
VCA of several measurements in MULDO, with a volume rate of 7 – 10 volumes per second, 
could enhance this confounding effect. 
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6.5 Semi- and fully automatic analysis and repeatability 
In both studies 1 and 2, the MULDO datasets were analyzed semi-automatically, and the 
observer had to investigate all of the frames from a recording and identify which frames to be 
measured. Inter-observer analysis in study 2, investigating the same recordings in 18 
participants, demonstrated a coefficient of repeatability of 8.7 mm2 for the semiautomatic 
analysis, corresponding to 9.8 mL. The criteria for inclusion and exclusion were well defined, 
but there were still some frames of uncertain nature, which explained the inter-observer 
variability. The measurement of the Doppler power and thus calculation of VCA was, 
however, performed automatically. In study 3, software identified all of the diastolic frames 
(volumes) during a recording of aortic regurgitation, making no manual interaction necessary, 
and thus making this a fully automatic method. We validated this fully automatic method in 
the first twenty participants in this study, and there was good agreement between semi-
automatic and fully automatic measurements of VCA by two independent observers. 
Additionally, in all patients, the recordings were validated by an observer to ensure that the 
Doppler power images displayed a jet above the noise level and that the vena contracta was 
within ROI, but no manual interaction or selection of frames were necessary. All data in study 
3 were based on fully automatic measurements of the VCA. In a separate and repeated 
recording from the same subject, we demonstrated a coefficient of repeatability for VCA of 
9.4 mm2. This is in agreement with the findings in study 1, in which the standard deviation of 
the in vitro VCA estimates was quite large. This can partly be explained by stochastic 
variations of the Doppler signal, which is demonstrated in paper 1. 
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7 Limitations 
The Nyquist limit of about 3 m/s for MULDO is usually lower than the maximum mitral and 
aortic regurgitant jet velocities. However, as long as the maximal velocity is less than two 
times the Nyquist velocity and the direction of the jet is known, the velocity of the jet can be 
determined unambiguously. To achieve HPRF, the ROI must be small in the radial direction. 
An ROI of 2 mm was challenging to apply in patients with mitral regurgitation. The size of 
ROI in the radial direction was extended as much as possible and up to 8 mm without any 
significant loss of velocity resolution. It can still be challenging to position the ROI correctly 
in vivo, especially with large displacements of the valve in hyperdynamic ventricles. As 
demonstrated in the simulation and to some degree in vitro in study 1, MULDO will 
overestimate the regurgitant orifice area in mild disease when the orifice is narrow relative to 
the size of the reference beam. This also corresponds with in vivo results. This limitation is 
inherent to similar techniques requiring reference measurements.104 For larger orifices, 
MULDO can underestimate the orifice size due to stochastic variations of the Doppler signals. 
Typically, the reference beam can be overestimated by up to 20% when up to 10 beams are 
candidates as the reference beam with most power. The in vitro results were however closer to 
the true values for larger orifices than the simulation predicted. The variability of repeated 
measurements is demonstrated in studies 1 and 3, and can partly be explained by stochastic 
variations of the Doppler signals.  
MULDO was validated for circular defects in vitro, but in vitro studies of non-circular 
defect are lacking. In study 2, we investigated both primary and secondary MR. Previous 
studies have demonstrated that the regurgitant orifices in vivo are frequently asymmetric and 
non-circular in the majority of patients with MR, but especially in secondary MR with a 
greater degree of asymmetry.55, 61, 63 We demonstrated better agreement between MULDO and 
MRI for primary (organic) than for secondary (functional) MR. This probably stems from the 
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same source as the overestimation of small orifices and thus mild MR. In addition, the 
regurgitant orifice may be large, but still not able to encompass the full reference beam due to 
asymmetry. 
The area estimation by MULDO is angle-dependent, and misalignment will lead to 
overestimation of the VCA. This overestimation of the VCA may be cancelled out by 
underestimation of the VTI by CW Doppler. The regurgitant volume relies on both correct 
measurement of the VCA and VTI. Consequently, different acquisitions by different probes 
raise the possibility of differences in beam alignment and thus errors in calculating the 
regurgitant volume.  
The vena contracta and ERO area can vary during systole,40, 45-47 and the current 
volume rate of 7 – 10 Hz is probably too low for short-duration regurgitation and dynamic 
variations. However, by MULDO, we used the median VCA from multiple frames, but this 
choice was somewhat arbitrary. If we had used the volume (frame) with the largest VCA, the 
comparison with 3D color Doppler in study 3 would have been more relevant. On the other 
hand, as the ERO area is dynamic and displays variability, we assumed that the median value 
of VCA would be an appropriate measure to report. In both the semi-automatic and fully 
automatic analyses, the median VCA were reported. In a similar way as in a number of the 3D 
color Doppler studies, we could have chosen “the most relevant lesion sizes”. As previously 
discussed, there is typically an early and late systolic peak and mid-systolic decrease or an 
early peak followed by a gradual decrease in flow rate in secondary (functional) MR, while in 
rheumatic disease, flow is relatively constant until a decrease in end-systolic and in mitral 
valve prolapse, there is a late-systolic increase in the flow.45, 46 We could have chosen these 
frames for MULDO in a semiautomatic approach, but not in a fully automatic approach as 
chosen in study 3.    
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In 3 out of 35 participants in study 2 and 7 out of 36 in study 3, we were not able to 
acquire representative Doppler data, because of a difficulty in identifying the vena contracta, 
or misalignment or incorrect positioning of the small ROI outside the vena contracta. Other 
clinical limitations may include an inability to hold the breath for 10 to 15 s, causing 
respiratory movements, and displacement of the ROI during acquisition. Poor acoustic 
windows or heavy valvular calcification can cause attenuation of the Doppler signals. 
Tachyarrhythmia can also be a limitation due to current volume (frame) rate.    
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8 Further perspectives 
Future generation of 3D probes are expected to have improved resolution, which will make it 
possible to obtain better estimates for the calibration beam and will enable MULDO to 
measure smaller orifices with less bias. By using a broad unfocused beam on transmit (plane 
wave transmission) and parallel receive beam forming, it is possible to increase the frame rate 
compared with conventional focused beam on transmit and receive, but with some reduction 
in spatial resolution. With an increased volume (frame) rate, regurgitant volume could be 
derived directly from the MULDO dataset. A PW Doppler technique measures radial 
velocities from a fixed spatial position and is susceptible to spectral broadening and aliasing. 
Similar to other Doppler techniques, MULDO is dependent on alignment of the direction of a 
regurgitant flow and the ultrasound beams, measuring radial velocities. 2D tracking Doppler 
is a new technique using plane wave transmissions and parallel receive beamforming, which 
can overcome some of the limitations of PW-Doppler. The blood scatterers can be followed 
along the direction of flow in the axial and lateral directions, giving less spectral broadening 
and higher spectral velocity resolution than PW-Doppler. This has been demonstrated in vitro 
and in carotid artery stenosis.115, 116  
There are, however, some challenges using tracking Doppler in a cardiac application 
compared to velocity estimation in the carotid artery using a linear probe. In cardiac 
applications, a phased-array probe is used with smaller aperture, and the region of interest is 
deeper. This leads to decreased spatial resolution. Further, the smaller width of plane waves 
transmitted from a phased array probe potentially limits the size of the tracking region for 
high velocities. In a recent study, tracking Doppler was investigated using a cardiac 
application in simulation and in vitro, and we performed an in vivo testing in a volunteer with 
mild to moderate AR (See Thesis of Jørgen Avdal at NTNU, 2015). Implementation for this 
technique on a 3D probe is a possible future improvement.  
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9 Conclusion 
In the present work with MULDO, we have demonstrated that: 
- In vitro: The cross sectional area of the vena contracta or vena contracta area (VCA) 
can be measured when the reference beam is entirely inside the regurgitant orifice. For 
small orifices, the estimate of the VCA can be overestimated.  
- In mitral regurgitation: The regurgitant volume, calculated from the VCA by MULDO 
and VTI by CW Doppler, significantly overestimated mild regurgitation, while there 
was no significant bias for moderate and severe MR when compared with regurgitant 
volume by MRI.  
- In aortic regurgitation: In this study, VCA by MULDO was calculated fully 
automatically, while VCA was calculated semi-automatically in the two previous 
studies. There was good agreement between regurgitant volume measured by MRI and 
regurgitant volume calculated from VCA by MULDO and VTI by CW Doppler in 
moderate and severe AR, while agreement for those with mild AR was modest with 
significant overestimation by MULDO. VCA measured by 3D color Doppler was 
significantly higher than VCA by MULDO. Agreement between VCA and AR grade 
by 2D echo was moderately good. 
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11 Appendix 
Forespørsel om deltagelse i en vitenskapelig undersøkelse: 
"Kvantitering av mitralinsuffisiens med en ny tredimensjonal (3D) hjerteultralyd sammenliknet med MR-undersøkelse av hjertet. 
" 
 
Ultralydundersøkelser for å kartlegge hjertets pumpeevne og eventuelle sykelige forandringer er i daglig bruk på sykehus verden over.  
 
Undersøkelsesmetoden er blitt svært populær fordi den er : 
1. Ufarlig 
2. Uten ubehag for pasienten.  
3. Gir verdifull informasjon om hjertets pumpeevne. 
 
Vi er stadig på jakt etter ny informasjon og viten for å forbedre metoden og tolke måleresultatene riktig. 
Beregning av størrelsen på lekkasjer gjennom hjerteklaffen mellom venstre forkammer og hovedkammer er vanskelig. Dagens metoder 
basert på todimensjonal ultralyd og hjertekateterisering har klare begrensninger.  
Det aktuelle forskningsprosjektet går ut på å bruke en ny metode for å kvantitere lekkasjen. Metoden er basert på tredimensjonal ultralyd og 
vil bli sammenlignet med etablerte metoder som er i daglig bruk ved Klinikk for Hjertemedisin ved St. Olavs Hospital. 
Rent praktisk vil undersøkelsen utføres med forsøkspersonen liggende på en benk i venstre sideleie og tar maksimalt en time. 
Undersøkelsen utføres ved Klinikk for Hjertemedisin. 
 
MR-undersøkelse av hjertet ved MR-senteret er en del av studien. Dette planlegges utført samme dag som ultralydundersøkelsen. Dette 
regnes også som en trygg undersøkelse og gir et mål på hvor stor lekkasjen er. Du må kunne ligge stille i en trommel i ca 30 min. mens 
undersøkelsen pågår.  Det er ingen smerte forbundet med undersøkelsen.  Du kan ikke delta dersom du har operert inn pacemaker, 
metallklips, metallproteser osv. Dersom du er plaget med klaustrofobi, kan det også være vanskelig å få gjennomført undersøkelsen. Her 
gjelder  vanlige retningslinjer for å  gjennomføre MR-undersøkelse. 
 
De nevnte undersøkelser i forbindelse med forskningsprosjektet kommer i tillegg til en ordinær ultralydundersøkelse utført ved Klinikk for 
Hjertemedisin. Det er frivillig å delta, og du kan når som helst trekke deg fra videre deltagelse uten at dette går ut over ordinær utredning 
eller behandling.  
 
Ved deltagelse i prosjektet vil det bli innhentet nødvendige opplysninger vedr. din hjertesykdom fra sykehusets pasientjournal. Deltagelse 
vil ikke anføres i din pasientjournal, og det vil ikke bli lagret opplysninger der.  
 
Prosjektmedarbeiderne har taushetsplikt i henhold til Forvaltningslovens § 13 og Helsepersonellovens § 21. Undersøkelsene utføres av leger 
og samarbeidspartnere i prosjektet. All informasjon og databehandling behandles konfidensielt og lagres etter vanlige retningslinjer.  
Prosjektet planlegges avsluttet ila mars 2009, og alle lagrede data vil da bli anonymisert.  
 
NTNU / Institutt for Sirkulasjon og Bildediagnostikk er ansvarlig for prosjektet. Prosjektet er tilrådd av personvernombudet for forskning, 
Norsk samfunnsvitenskapelig  datatjeneste AS og av Regional komité for medisinsk og helsefaglig forskningsetikk ( REK i Midt-Norge ). 
 
Ordningen for pasientskadeerstatning omfatter også forsøkspersoner som deltar i medisinsk forskning. 
 
Ved spørsmål kan du ta kontakt  med prosjektmedarbeider / lege Thomas R. Skaug, som organiserer den praktiske gjennomføringen (tlf 
72470000- medisinsk avd., St. Olavs Hospital, avd. Orkdal eller 40607557 ) eller evt med prosjektleder (tlf 73868000- Klinikk for 
hjertemedisin, St. Olavs Hospital og 73598888-NTNU, ISB ) for mer informasjon. 
 
Returneres  til : 
 
Prosjektleder Bjørn Olav Haugen 
Institutt for Sirkulasjon og Bildediagnostikk (ISB ) 
Det medisinske fakultet, NTNU 
Medisinsk teknisk forskningssenter 
7489 Trondheim 
 
 
Samtykkeskjema for deltagelse i klaffelekkasje-studien som er beskrevet over 
 
 
Jeg har mottatt skriftlig og muntlig informasjon og er villig til å delta i studien. 
 
 
 
Trondheim        /           2008. 
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Forespørsel om deltagelse i en vitenskapelig undersøkelse:  
"Kvantitering av aortainsuffisiens med en ny tredimensjonal (3D) hjerteultralyd sammenliknet med MR-undersøkelse av 
hjertet. "  
   
Ultralydundersøkelser for å kartlegge hjertets pumpeevne og eventuelle sykelige forandringer er i daglig bruk på sykehus 
verden over.  
   
Undersøkelsesmetoden er blitt svært populær fordi den er:  
1.   Ufarlig  
2.   Uten ubehag for pasienten.  
3.   Gir verdifull informasjon om hjertets pumpeevne.  
   
Vi er stadig på jakt etter ny informasjon og viten for å forbedre metoden og tolke måleresultatene riktig.  
Beregning av størrelsen på lekkasjer gjennom hjerteklaffen mellom hovedpulsåra og venstre hjertekammer er vanskelig. 
Dagens metoder basert på todimensjonal ultralyd og hjertekateterisering har klare begrensninger.  
Det aktuelle forskningsprosjektet går ut på å bruke en ny metode for å kvantitere lekkasjen. Metoden er basert på 
tredimensjonal ultralyd og vil bli sammenlignet med etablerte metoder som er i daglig bruk ved Klinikk for Hjertemedisin ved 
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Purpose: A new three-dimensional (3D) high pulse repetition frequency (hprf) Doppler method called 
MULDO (MULtibeam hprf Doppler) has been developed to calculate the cross sectional area of the vena 
contracta (VCA) and quantify the severity of mitral regurgitation (MR). 
 
Methods: The power of the received Doppler signal is proportional to the amount of blood flowing 
through the sample volume. We have isolated the Doppler signal from mitral jet flow by using MULDO. It 
uses a very high pulse repetition frequency, giving a Nyquist limit near the peak velocity of the jet. The 
VCA is found by summing the power of the Doppler signal from multiple beams distributed over the 
laminar vena contracta region and compensating for the attenuation and beam geometry by using a 
reference beam within the jet. 
 
Materials: In a preliminary study five patients with moderate to moderate-severe MR (grade 2 and 3) 
were investigated by two-dimensional (2D) echocardiography and MULDO. 
 
Results: The results are presented in the table. 
 
Conclusion: As expected there are some discrepancy between the various methods to determine the 
severity of MR.The MULDO method does not make assumptions about the geometry and is not gain 
dependent. We believe that it will become a valuable tool in quantification of MR but warrants further 
investigations. 
Table 
 
Case  2D grade(a)  2D grade(b)  PISA-EROA  MULDO-VCA  PISA-RV  MULDO-RV 
 
1  2  3  0,60  0,68  53  61 
             
2  2  2-3  0,44  0,24  44  24 
             
3  2-3  3  0,39  0,26  76  51 
             
4  3  3  0,36  0,33  34  31 
             
5  2-3  2-3  0,36  0,40  51  57 
             
 
2D echocardiographic qualitative grading (grade 1-4; mild-moderate-moderate severe-severe) by two 
investigators (a and b), effective regurgitant orifice area (EROA=cm2) and regurgitant volume 
(RV=ml/beat) calculated by the 2D PISA method, VCA (cm2) by MULDO and MULDO-RV (ml/beat) 
calculated as the product of MULDO-VCA and 2D CW Doppler Velocity Time Integral of the regurgitant 
jet. 
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Paper 2
CLINICAL INVESTIGATIONS
VALVULAR HEART DISEASE
Quantification of Mitral Regurgitation Using High Pulse
Repetition Frequency Three-Dimensional Color
Doppler
Thomas R. Skaug, MD, Torbjørn Hergum, MSc, Brage H. Amundsen, MD, PhD, Terje Skjærpe, MD, PhD,
Hans Torp, MSc, Dr Techn, and Bjørn Olav Haugen, MD, PhD, Trondheim, Norway
Background: The aim of this study was to validate a novel method of determining vena contracta area (VCA)
and quantifying mitral regurgitation using multibeam high–pulse repetition frequency (HPRF) color Doppler.
Methods: The Doppler signal was isolated from the regurgitant jet, and VCA was found by summing the Dopp-
ler power from multiple beams within the vena contracta region, where calibration was done with a reference
beam. In 27 patients, regurgitant volumewas calculated as the product of VCA and the velocity-time integral of
the regurgitant jet, measured by continuous-wave Doppler, and compared with regurgitant volume measured
by magnetic resonance imaging (MRI).
Results: Spearman’s rank correlation and the 95% limits of agreement between regurgitant volume measured
by MRI and by multibeam HPRF color Doppler were rs = 0.82 and 3.0 6 26.2 mL, respectively.
Conclusion: For moderate to severe mitral regurgitation, there was good agreement between MRI and multi-
beam HPRF color Doppler. Agreement was lower in mild regurgitation. (J Am Soc Echocardiogr 2010;
23:1-8.)
Keywords: Mitral regurgitation, Multibeam HPRF color Doppler, PISA, Vena contracta area, Regurgitant
volume
The echocardiographic assessment of the severity of mitral regurgita-
tion (MR) is challenging, because it requires the integration of differ-
ent 2-dimensional (2D) Doppler parameters with inherent strengths
and weaknesses.1 The proximal isovelocity surface area (PISA)
method provides measures of mitral regurgitant flow rate, effective re-
gurgitant orifice area (EROA) and regurgitant volume.2-4 However,
the PISA method has limitations because the regurgitation is dynamic
throughout systole and because it assumes a hemispheric flow
convergence and a circular regurgitant orifice.5-8 A different approach
to quantify MR is to look at the vena contracta, which is slightly
smaller than the anatomic orifice and thus a measure of EROA.1
According to guidelines, a vena contracta width $ 7 mm and an
EROA and regurgitant volume as measured by PISA $ 0.4 cm2
and $ 60 mL, respectively, are regarded as specific signs of severe
MR.1,9 Three-dimensional (3D) color flow imaging (CFI) can be
used to quantify the vena contracta area (VCA)10-12 and PISA.13,14
Measuring the VCA by planimetry of 3D CFI has shown better cor-
relation with angiographic grading than measuring the vena contracta
width by 2D CFI.10 The shape of the VCAwas investigated using 3D
CFI and demonstrated to be noncircular in functional MR, resulting in
poor estimation of EROA by measuring the vena contracta width.12
In laminar blood flow such as in the vena contracta, the backscat-
tered Doppler power is proportional to the volume of blood in the
sample volume of an ultrasound beam.15 This can be calibrated to
give an absolute measurement of volume flow, as was shown for mea-
surements in arteries by Hottinger and Meindl16 in 1979. This princi-
ple can be used in the quantification of MR, as shown by Buck et al,17
who estimated volume flow through the vena contracta from the
power-velocity integral by means of a single wide measurement
beam and a narrow beam for calibration.
We have recently extended this principle17 to usingmultiple beams
covering the vena contracta. Summing these beams provides a more
homogeneous measurement compared with using a single beam. The
proposed method has recently been validated in vitro as well as in
computer simulations.18 In this study, the proposed method was
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used in vivo to quantify VCA semiautomatically, which was multi-
plied by the velocity-time integral (VTI), found independently using
continuous-wave (CW) Doppler, to obtain the regurgitant volume.
We used magnetic resonance imaging (MRI) as one of the reference
methods for flow quantification of MR, which has previously been
validated for this purpose.19,20
METHODS
Multibeam High–Pulse Repetition Frequency (HPRF) Color
Doppler
The maximum velocity (the Nyquist limit) that can be resolved with
CFI is typically 1 m/s for cardiac applications, which is much lower
than the typical velocity of 4 to 6 m/s in a MR jet. We increased
the Nyquist limit using a custom 3D HPRF color Doppler mode.
With HPRF, several pulses are fired before the deep echoes from
the first pulse have returned to the probe, such that exact range infor-
mation is lost in exchange for an increased velocity span. However,
this is not a problem, because the spurious sample volumes are out-
side the jet, and these signals are removed by a high-pass filter. Several
ultrasound beams are spread out across the valve, as shown in the left
part of Figure 1, and 3D Doppler data are recorded from a wide but
short region of interest (ROI) covering the vena contracta. (The ROI
must be short radially to enable HPRF.) A composite measurement
beam is made by summing the contribution from all the beams.
The right part of Figure 1 shows these individual beams (black) to
scale, together with the composite measurement beam (blue). A
wide single measurement beam (green), as used by Buck et al,17 is in-
cluded for comparison. The composite beam has a more homoge-
neous sensitivity and a higher signal-to-noise ratio than the single
wide beam. Additional beams can be included tomake the composite
beam arbitrarily large without decreases in signal-to-noise ratio.
Blood flow through the vena contracta is known to be laminar, and
for laminar blood flow, the power of the Doppler signal, Pmeas, is pro-
portional to the blood volume within the sample volume. The factor
of proportionality, the ratio of the Doppler power Pref to the beam
area Aref, is determined from the beamwith the most Doppler power,
because this beam is most likely to be within the regurgitant jet or or-
ifice, as demonstrated in the left part of Figure 1. A computer model
provides the cross-sectional area, Aref, as well as a constant, k, relating
the power of the composite beam to the reference beam. Because the
power-to-area ratio is constant, the VCA is found by solving
Pmeas
VCA
¼ k  Pref
Aref
:
Being a numerical method, it is independent of display parameters
such as gain and tissue priority. The reason ‘‘color’’ is included in ‘‘3D
HPRF color Doppler’’ is because the acquisition uses just a few beams
in each direction, just like CFI, compared with pulsed wave Doppler,
which typically uses 50 to 100 pulses to make one spectrum. A few
samples are sufficient to separate the Doppler power from the high-
velocity jet from the surroundings, enabling a reasonable frame
rate. However, it is dependent on the transmit frequency and trans-
ducer size for lateral resolution, which ultimately limits minimum
beam width and thus valid calibration measurements. Additionally,
the grid of beams makes it possible to obtain cross-sectional images
of the vena contracta, but this was not investigated in this study.
Further details can be found in Hergum et al.18
Data Acquisition and Processing
Equipment. A Vivid 7 Dimension (GE Vingmed Ultrasound AS,
Horten, Norway) with a 3V matrix-array probe and an M4S 2D
cardiac probe was used to acquire HPRF 3D color Doppler and stan-
dard 2D images. Custom software was used for postprocessing of the
raw 3D Doppler data to calculate VCA. EchoPAC (GE Vingmed
Ultrasound AS) was used to analyze the 2D images.
Subjects. The study was performed at the Department of Cardiol-
ogy of St Olav’s Hospital (Trondheim, Norway). The primary
exclusion criteria were aortic regurgitation, cardiac arrhythmias, and
contraindications to MRI. Of 35 subjects with mild to severe MR
who consented to participate, 3 were excluded because of poor mul-
tibeam HPRF color Doppler quality, 4 because of poor MRI quality
caused by arrhythmias, and 1 because of a requirement for hemodi-
alysis between investigations. Consequently, the study included 27
subjects, 11 women and 16 men, with a median age of 51 years
(range, 28-81 years). Sixteen subjects had organic mitral valve disease
or unidentified etiology, and 11 had functional regurgitation. Eccen-
tric jets were present in 10 of 16 patients with organic MR and in 4
of 11 subjects with functional MR. All were in sinus rhythm, and
the median ejection fraction measured by echocardiography was
50% (range, 23%-65%). The interval between the examinations
was within 1 day in 22 of the subjects and within 1 to 5 days in 5 sub-
jects, and there were no changes in medications. The median heart
rate was 63 beats/min (range, 43-104 beats/min) during Doppler
echocardiography and 64 beats/min (range, 48-110 beats/min) dur-
ing MRI. The study was approved by the Regional Committee for
Medical and Health Research Ethics, Norwegian Social Science
Data Service, and conducted according to the Declaration of Helsinki.
Two-Dimensional Doppler Echocardiography. A standard 2D
Doppler echocardiographic examination was performed, including
an assessment of jet area by CFI compared with left atrial size and mi-
tral and pulmonary vein flow. We measured the mitral regurgitant
flow rate by PISA at the time of peak regurgitant jet velocity. The
Nyquist limit was lowered, such that a flow convergence as close as
possible to a hemisphere was shown in an apical view. The VTI and
peak regurgitant jet velocity were measured using CW Doppler,
and the PISA EROA and regurgitant volume were calculated using
a hemispheric approach.1,4 We were unable to assess the PISA flow
rate in 5 subjects. A highly qualified echocardiography observer,
blinded to the MRI and multibeam HPRF color Doppler results, ana-
lyzed PISA and MR grade as follows: 1 = mild, 2 = mild to moderate,
3 = moderate to severe, and 4 = severe.
Multibeam HPRF Color Doppler. Multibeam HPRF color Dopp-
ler recordings were made in the apical view in two steps, as illustrated
in Figure 2. With the scanner in triplex mode (B mode, CFI, and
pulsed-wave Doppler), the vena contracta was located by moving
the pulsed-wave sample volume into the jet flow shown by CFI and
adjusted to include the highest velocities. The scanner was then
switched to the custom multibeam HPRF color Doppler mode,
with the position of the 3D ROI centered around the pulsed-wave
sample volume. Depending on the depth of the ROI, the transmit fre-
quency and the pulse repetition frequency were set to obtain
a Nyquist velocity of about 3 m/s, so that a jet flow of nearly 6 m/s
could be resolved. Typically, the transmit frequency was 2.1 MHz
and the pulse repetition frequency 20 kHz. In a typical subject, the
depth of the ROI was at about 9 - 10 cm. Altering display parameters
such as gain and tissue priority during acquisition to visualize the
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regurgitant jet optimally did not affect the raw 3D Doppler data we
used for analysis. Each recording consisted of several cycles of real-
time data, and the procedure was repeated to make sure that the
vena contracta was within the ROI despite patient movement. The
size of the ROI was 7  20  21 mm (radial azimuth  elevation).
Currently, the frame rate is limited to about 10 volumes/s because of
the large number of transmitted ultrasound beams necessary for each
acquired volume. The raw 3DDoppler data were analyzed semiauto-
matically to find the VCA using custom software. Radial smoothing
was applied to reduce the variance of the estimates. Frames corre-
sponding to the systolic jet were selected, and the estimate of the
VCA was the median value of these measurements. Some frames
were excluded according to the following criteria:
 there was no visible jet above the noise level,
 the ROI did not cover the jet area, or
 the vena contracta was not within the ROI.
Multibeam HPRF color Doppler was analyzed by an observer
blinded to the MRI data, MR grade, and the PISA results. To assess in-
terobserver variability, another blinded observer randomly analyzed
18 of the subjects. The multibeam HPRF color Doppler regurgitant
volume was calculated as the product of the VCA and the VTI of
the regurgitant jet, measured separately by CW Doppler. Because
the direction of flow was known, the velocity could also be found
from the color flow data by maximum baseline shift. However, we
chose to use separate VTI measurement because of the current low
temporal resolution of 3D color flow data.
MRI Study. All patients were examined during supine rest using
a Siemens Avanto 1.5-T system with a body matrix coil (Siemens
Medical Systems, Erlangen, Germany). True fast imaging with
steady-state precession cine images were acquired during end-ex-
piratory breath holds in the 4-chamber and 2-chamber views and
in the short axis from the base to the apex of the left ventricle
with the following settings: retrospective electrocardiographic gat-
ing; in-plane resolution, 0.9  0.9 mm; echo time, 1.12 ms;
repetition time, 58 ms; flip angle, 80; slice thickness, 6 mm; slice
gap, 4 mm; and 25 to 30 frames/beat. Flow in the ascending
aorta was quantified using a steady-state free precession phase-
contrast sequence with the following settings: retrospective
electrocardiographic gating; in-plane resolution, 1.3  1.3 mm;
minimal repetition time (61.05 ms) and echo time (3.09 ms); slice
thickness, 6 mm; encoding velocity adjusted to just above
maximal systolic velocities; and 25 to 30 frames/beat. All images
were analyzed using Segment21 by an observer unaware of the
echocardiographic results. The left ventricular stroke volume was
calculated by semiautomatically drawing endocardial contours in
the short-axis images in end-diastole and end-systole (aortic valve
closure). Systolic long-axis excursion was quantified by measuring
the descent of the septal, lateral, inferior, and anterior points of
the mitral annulus in the 4-chamber and 2-chamber views. The
average value was incorporated into the stroke volume estimate
in the software. Systolic flow in the ascending aorta was quanti-
fied from the phase-contrast images by drawing an ROI in the as-
cending aorta. The MRI regurgitant volume was quantified as the
difference between the left ventricular stroke volume and the aor-
tic stroke volume.19 The accuracy of the method was tested in an
in vivo validation study in which the same measurements as de-
scribed above were done in 9 subjects (4 healthy subjects, 5
with recent myocardial infarctions) in whom the absence of MR
was confirmed by echocardiography. The estimated error was 3
6 5 mL/stroke.
Statistical Analysis. The null hypothesis corresponded to no dif-
ference between the multibeam HPRF color Doppler, MRI, and 2D
echocardiography in the quantification of MR. Including 27 patients
resulted in power > 90% at the 5% significance level for detecting
a difference in regurgitation volume of 5 mL, assuming 1 standard de-
viation (SD) of 3.2 mL. Spearman’s rank correlation (rs) was used be-
cause the continuous variables were not normally distributed. The
agreement between the continuous variables (multibeamHPRF color
Doppler, MRI, and PISA) was assessed by calculating the 95% limits
of agreement (mean difference 6 2 SDs).22 Because the differences
were normally distributed, we used paired-samples t tests to compare
the regurgitant volume measured by the different methods as well as
the heart rate. To assess the agreement between MR grade (1-4), MRI
regurgitant volume (milliliters per beat), multibeam HPRF color
Doppler regurgitant volume (milliliters per beat), and VCA (square
millimeters), we used k statistics. In accordance with current guide-
lines for EROA, we divided the VCA results into 4 categories:
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Figure 1 (A) Sketch of a leaking valve, with multiple beams shown. The reference beam (red), the beamwith themost Doppler power,
is selected automatically as the beam that is most likely to be within the orifice. A composite measurement beam is made by adding
multiple narrow beams together. (B) In this 2D sketch, 9 narrow beams have been added to make a wide, flat beam. The green line
shows the beam profile of a single wide beam from a smaller transducer. The peak sensitivity of this beam is about 8 dB lower than for
the blue composite beam, and the sensitivity varies significantly.
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1 = 0 to 19mm2, 2 = 20 to 29mm2, 3 = 30 to 39mm2, and 4 =$40
mm2. We divided regurgitant volume into 4 categories: 1 = 0 to 29
mL, 2 = 30 to 44 mL, 3 = 45 to 59 mL, and 4 = $60 mL.1
We assessed the interobserver variability of the multibeam HPRF
color Doppler VCA and regurgitant volume in 18 subjects as the
coefficient of repeatability, defined as 2 SDs of the differences.
Descriptive values are reported as medians and ranges, and 95%
limits of agreement are reported as mean 6 2 SDs. Results of paired
t tests are reported as mean (95% confidence interval [CI]). The sta-
tistical analyses were performed using SPSS (SPSS, Inc, Chicago, IL).
RESULTS
The descriptive results are presented in Table 1. The mean difference
in heart rate between MRI and Doppler echocardiography was 2.4
beats/min (95% CI, 1.4 to 6.2 beats/min).
Spearman’s rankcorrelation (n=27)was better between regurgitant
volume measured by MRI and multibeam HPRF color Doppler (rs =
0.82, P < .001) than betweenMRI regurgitant volume and multibeam
HPRF color Doppler VCA (rs = 0.64, P < .001). Similarly, Spearman’s
rank correlation was better between MR grade and multibeam HPRF
color Doppler regurgitant volume (rs = 0.66, P < .001) than between
MR grade and multibeam HPRF color Doppler VCA (rs = 0.41, P =
.036). The 95% limits of agreement between regurgitant volumemea-
sured byMRI andmultibeamHPRF colorDoppler (n= 27)were3.0
6 26.2mL.Omitting the 5 subjects (n = 22) inwhomwewere unable
to measure PISA, Spearman’s rank correlation and the 95% limits of
agreement between regurgitant volume measured by MRI and multi-
beam HPRF color Doppler were rs = 0.79 (P < .001) and 5.1 6
23.9 mL, respectively (Figure 3a). Similarly, Spearman’s rank correla-
tion and the 95% limits of agreement between MRI and PISA were
rs = 0.78 (P < .001) and 4.76 30.6 mL, respectively (Figure 3b), and
between PISA and multibeam HPRF color Doppler were rs = 0.63
(P = .002) and 9.86 37.0 mL, respectively (Figure 3c). Spearman’s
rank correlation between PISA EROA and multibeam HPRF color
Doppler VCA was rs = 0.40 (P = .065), and the 95% limits of agree-
ment were0.086 0.28 cm2. There was no significant difference be-
tween regurgitant volume measured by MRI and multibeam HPRF
color Doppler or between MRI and PISA. Both PISA regurgitant vol-
ume and PISA EROAwere significantly lower than multibeam HPRF
color Doppler regurgitant volume and VCA.
There was a significant difference between regurgitant volume
measured by MRI and multibeam HPRF color Doppler in patients
with mild MR, defined as MRI regurgitant volume < 30 mL (n =
13), with a mean difference of 11.8 mL (95% CI, 17.9 to 5.6
mL). In patients with moderate and severeMR, defined as MRI regur-
gitant volume$ 30mL (n = 14), the mean difference between regur-
gitant volumemeasured byMRI andmultibeamHPRF color Doppler
was 5.2 mL (95% CI, 0.6 to 11.0 mL). The mean difference be-
tween regurgitant volume measured by MRI and multibeam HPRF
color Doppler was 1.1 mL (95% CI, 5.7 to 7.9 mL) in organic
MR, while the mean difference was 8.8 mL (95% CI, 16.8 to
0.8 mL) in functional MR. There were no significant differences be-
tween regurgitant volume measured by MRI and multibeam HPRF
color Doppler in central and eccentric mitral regurgitant jets. The
mean differences were 2.0 mL (95% CI, 10.9 to 7.0 mL) and
3.8 mL (95% CI, 10.7 to 3.1 mL), respectively.
The k agreement between the various methods is presented in
Table 2 and Figure 4. Agreement between the methods was better
for organic than functional MR, as seen in Table 2.
Interobserver analysis of the multibeam HPRF color Doppler VCA
in 18 subjects demonstrated that the coefficient of repeatability was
8.7 mm2. Because of the interobserver variability with VCA, the co-
efficient of repeatability for multibeam HPRF color Doppler regurgi-
tant volume was 9.8 mL.
Table 1 Study results
Variable Median Range
MULDO VCA (mm2) (n = 27) 25.7 12.0-59.0
VTI by CW Doppler (cm) (n = 27) 150 74-213
Peak jet velocity by CW Doppler (m/s) (n = 27) 5.3 4.3-6.3
MULDO regurgitant volume (mL) (n = 27) 35.6 14.2-99.0
In functional MR (n = 11) 32.3 14.5-54.2
In organic MR (n = 16) 39.8 14.2-99.0
In central MR (n = 13) 32.3 14.2-99.0
In eccentric MR (n = 14) 37.7 20.0-61.3
MRI regurgitant volume (mL) (n = 27) 35.1 4.2-129.0
In functional MR (n = 11) 14.3 7.8-46.3
In organic MR (n = 16) 47.1 4.2-129.0
In central MR (n = 13) 23.9 8.3-129.0
In eccentric MR (n = 14) 45.2 4.2-68.7
PISA regurgitant volume (mL) (n = 22) 22.2 2.2-80.0
MULDO, Multibeam HPRF color Doppler.
Figure 2 Two-step multibeam HPRF color Doppler data acqui-
sition. (Top) Triplex scan. (Bottom) Three-dimensional HPRF
color flow of the vena contracta. Note the Nyquist limit and the
ROI. The VCA was calculated from the Doppler power; not the
color flow images.
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DISCUSSION
In patients with more than mild mitral regurgitant jets evaluated by
standard 2D Doppler echocardiography, it is necessary to quantify
the regurgitant volume to discriminate between moderate and severe
MR.1 The present study shows that the severity of MR can be quanti-
fied with a new 3D echocardiographic method based on multibeam
HPRF color Doppler. The method is an extension of a previous
A
B
C
Figure 3 Spearman’s rank correlation and 95% limits of agreement between regurgitant volume (Reg. Vol.) (n = 27) measured by (A)
MRI and multibeam HPRF color Doppler (MULDO) were rs = 0.82 and 3.0 6 26.2 mL, respectively. Omitting the 5 subjects (open
dots) in whom we were unable to measure PISA, Spearman’s rank correlation and the 95% limits of agreement between regurgitant
volume (n = 22) measured by MRI and multibeam HPRF color Doppler were rs = 0.79 and 5.1 6 23.9 mL, respectively. (B)
Spearman’s rank correlation and 95% limits of agreement between MRI and PISA were rs = 0.78 and 4.7 6 30.6 mL, respectively.
(C) Spearman’s rank correlation and 95% limits of agreement between PISA and multibeam HPRF color Doppler were rs = 0.63
and 9.8 6 37.0 mL, respectively.
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method described by Buck et al.17 VCAwas measured from the back-
scatteredDoppler power, while the regurgitant volumewas calculated
as the product of VCA and the VTI of the regurgitant jet, found sepa-
rately fromCWDoppler. The agreement between regurgitant volume
measured by MRI and multibeam HPRF color Doppler and between
MR grade and multibeam HPRF color Doppler regurgitant volume
was moderately good. In organic MR, the agreement between the
methods was even better, and there was no significant difference be-
tween regurgitant volume measured by MRI and multibeam HPRF
color Doppler. The agreement was poor in functional MR, with the
multibeam HPRF color Doppler regurgitant volume being signifi-
cantly higher. Similarly, in patients with MRI regurgitant volumes <
30mL, therewas significant overestimation bymultibeamHPRF color
Doppler regurgitant volume, but there was no bias in those with MRI
regurgitant volumes$ 30mL. The 95% limits of agreement between
regurgitant volume measured by MRI and multibeam HPRF color
Doppler were relatively wide, which is explained by the significant
overestimation ofmild regurgitation bymultibeamHPRF color Dopp-
ler. Unlike direct measurement with planimetry of VCA by 3D CFI,10
multibeam HPRF color Doppler estimates VCA on the basis of a
calibrated measurement of the backscattered Doppler power and
requires no manual tracing; the calculations can be done semiauto-
matically, are not affected by display settings such as gain and tissue pri-
ority, and are not limited by a Nyquist limit of <1 m/s. The major
advantage of extending the method from one measurement beam
and one reference beam17 to multiple beams is more homogeneous
sensitivity of themeasurement beam,which ensures that a slight lateral
shift of the ROI will not result in a different measurement. The signal-
to-noise ratio is also improved. Because the reference beam is
automatically selected within a grid of beams, it is easier for the sonog-
rapher to obtain a valid reference measurement, compared with the
use of only a single beam.
In the present study, we found better correlation and agreement
between regurgitant volume measured by MRI and multibeam
HPRF color Doppler than betweenMRI regurgitant volume and mul-
tibeam HPRF color Doppler VCA. This is not surprising, because the
regurgitant volume is given not only by the EROA but also by the du-
ration of regurgitation and the pressure gradient across the mitral
valve, expressed as the VTI. As demonstrated in Figure 3a, the 95%
limits of agreement between regurgitant volume measured by MRI
andmultibeamHPRF color Doppler were wide in our study, whereas
Buck et al23 demonstrated excellent agreement. They reported
a mean difference of 0.4 mL and 1 standard deviation of 3.2 mL, cor-
responding to 95% limits of agreement of 0.4 6 6.4 mL, between
broad-beam spectral Doppler and MRI measurements in MR. There
are some differences to note. Our population was characterized by
a wider range of regurgitant volume measured by MRI (4-129 mL)
than in the population investigated by Buck et al23 (6-46 mL). Sec-
ond, we measured VCA by multibeam HPRF color Doppler, but
the VTI of the regurgitant jet was measured separately by CWDopp-
ler. In the power-velocity integral method used by Buck et al,23 both
the area and the velocity integral across the flow cross-sectional area
were measured. Further, the calculation of MRI regurgitant volume
was somewhat different, as we calculated the left ventricular stroke
volume by volumetric measurements in short-axis and long-axis im-
ages, whereas Buck et al23 measured mitral inflow using phase con-
trast imaging. Another recently described 3D CFI method based on
Table 2 Agreement
Agreement k P
MRI regurgitant volume vs MULDO VCA (n = 27) 0.32 .005
MRI vs MULDO regurgitant volume (n = 27) 0.49 < .001
MR grade vs MULDO VCA (n = 27) 0.12 .30
MR grade vs MULDO regurgitant volume (n = 27) 0.44 < .001
MR grade vs MRI regurgitant volume (n = 27) 0.48 < .001
MRI vsMULDO regurgitant volume in functionalMR
(n = 11)
0.11 .60
MR grade vs MULDO regurgitant volume in
functional MR (n = 11)
0.19 .36
MR grade vs MRI regurgitant volume in functional
MR (n = 11)
0.30 .12
MRI vs MULDO regurgitant volume in organic MR
(n = 16)
0.67 < .001
MR grade vs MULDO regurgitant volume in organic
MR (n = 16)
0.58 < .001
MR grade vs MRI regurgitant volume in organic MR
(n = 16)
0.57 < .001
MULDO, Multibeam HPRF color Doppler.
Multibeam HPRF color Doppler and MRI regurgitant volume categories:
1 = 0 to 29 mL, 2 = 30 to 44 mL, 3 = 45 to 59 mL, and 4 =$60 mL. Multi-
beamHPRF color Doppler VCA categories: 1 = 0 to 19mm2, 2 = 20 to 29
mm2, 3 = 30 to 39mm2, 4 =$40mm2. MR grades assessed by 2D echo:
1 = mild, 2 = mild to moderate, 3 = moderate to severe, 4 = severe.
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Figure 4 The k agreement (n = 27) betweenMRgrade andmulti-
beam HPRF color Doppler (MULDO) regurgitant volume (Reg.
Vol.), between MR grade and MRI regurgitant volume, and be-
tween regurgitant volume measured by MRI and multibeam
HPRF color Doppler was 0.44, 0.48, and 0.49, respectively.
MR grades assessed by 2D echo: 1 =mild, 2 =mild tomoderate,
3 = moderate to severe, 4 = severe. Multibeam HPRF color
Doppler and MRI regurgitant volume categories: 1 = 0 to 29
mL, 2 = 30 to 44 mL, 3 = 45 to 59 mL, and 4 = $60 mL.
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dealiasing of mitral vena contracta flow to calculate mitral regurgitant
volume was validated by Plicht et al,24 and the 95% limits of agree-
ment between this 3D CFI method and MRI in vivo were 1.8 6
14.2 mL. In our study, in vivo validation results showed that the
MRI measurements contributed only to a modest part of the total dif-
ference between the methods, and the error was in the same range as
previously reported for the approach used by Buck et al and Plicht
et al.20,23,24 We demonstrated significant overestimation by multi-
beam HPRF color Doppler regurgitant volume for mild regurgitation,
defined as MRI regurgitant volume < 30 mL, but no significant bias
for MRI regurgitant volume $ 30 mL. Similarly, in vitro, there was
an overestimation of the VCA in the small valvular defects.18
We found a significant correlation (rs = 0.66) and moderately good
agreement (k = 0.44) betweenMR grade and multibeamHPRF color
Doppler regurgitant volume. The fact that multibeam HPRF color
Doppler overestimates mild regurgitation (regurgitant volume < 30
mL) is clearly illustrated in Figure 4. This contributes to some overlap
between MR grades 1 and 2. Agreement was better for organic than
for functional MR between the various methods, as demonstrated in
Table 2. This probably stems from the same source as the overestima-
tion of mild regurgitation: the reference beams are too large for some
orifices. The regurgitant orifice is usually asymmetric and noncircular
in functional as opposed to organic MR,12,13 meaning that the cross-
sectional area may be large but still not able to encompass the full ref-
erence beam. Additionally, those with an organic etiology in our study
were part of a higher regurgitant volume population than those with
a functional etiology.
In our study, a standard hemispheric PISAwas feasible in 22 out of
27 patients. The 95% limits of agreement between regurgitant volume
measured by MRI and PISAwere wider than between MRI and multi-
beam HPRF color Doppler (Figure 3). One of the limitations of this
PISA method is the dynamic variation of the mitral regurgitant flow
rate and the EROAduring systole.6,7 This was demonstrated in a valida-
tion study using 4 different hemispheric PISA methods. There was sig-
nificant underestimation of mitral regurgitant volume by two single-
point PISA methods, measuring instantaneous flow rate, compared
with MRI (95% limits of agreement, 13.3 6 20.4 and 13.5 6
20.6 mL) and to a lesser degree by two time-integral PISA methods
compared with MRI (95% limits of agreement, 8.0 6 12.8 and
8.7 6 14.8 mL).8 In 3D CFI studies, it has been demonstrated that
the proximal flow convergence area is hemielliptic rather than hemi-
spheric, especially in functional MR, because of the asymmetric geom-
etry of the regurgitant orifice area. This results in significant
underestimation of PISA EROAmeasured by a hemispheric approach
by 2D CFI.13,14 Similarly, VCAmeasured by 3D CFI has been demon-
strated to be significantly larger than PISA EROAmeasured by a hemi-
spheric approach, especially in patients with elliptical orifice shapes.12,25
Kahlert et al12 demonstrated that the 95% limits of agreement between
PISA EROA measured by a hemispheric and a hemielliptic approach,
respectively, and VCA measured by 3D CFI were 0.2 6 0.4 and
0.096 0.28 cm2, respectively. We demonstrated that the 95% limits
of agreement between regurgitant volumemeasured by a hemispheric
approach to PISA and multibeam HPRF color Doppler were wide
(Figure 3c). Multibeam HPRF color Doppler regurgitant volume was
significantly larger than PISA regurgitant volume, and multibeam
HPRF color Doppler VCAwas significantly larger than PISA EROA.
Limitations
The Nyquist limit should ideally be equal to the mitral regurgitant jet
velocity. However, the velocity of the mitral regurgitant jet can be
determined unambiguously as long as the direction of the jet is
known and the peak velocity is <2 times the Nyquist limit of about
3 m/s. To achieve such an HPRF, and thus a high Nyquist limit, the
ROI must be small in the radial direction. It can be challenging to
position the ROI correctly, especially with large displacements of
the mitral valve in hyperdynamic ventricles. As shown in the exper-
imental study, multibeam HPRF color Doppler VCA will overesti-
mate the regurgitant orifice area in mild disease when the orifice is
narrow relative to the size of the reference beam.18 This limitation
is inherent to all similar techniques requiring reference measure-
ments.17 Accordingly, agreement was better for the moderate and
severe regurgitations in the present study. The regurgitant volume re-
lies on measuring both the multibeam HPRF color Doppler VCA
and VTI of the regurgitant jet by CW Doppler accurately. Area esti-
mation by multibeam HPRF color Doppler is angle dependent, like
other Doppler methods, and misalignment will overestimate VCA.
The regurgitant volume will not be angle dependent, because the
overestimation of VCA will be canceled out by the underestimation
of the VTI from CW Doppler. The vena contracta and the EROA
can vary during systole,1,6-8,26 and the current frame rate of 10 vol-
umes/s is probably too low for short-duration regurgitation or dy-
namic variations during systole. However, multibeam HPRF color
Doppler acquires real-time data over several cardiac cycles to
make sure that the vena contracta is within the 3D ROI. The criteria
for the inclusion and exclusion of frames were well defined, but
there were still some frames that were of uncertain nature, which
explains the interobserver variability of the VCA.
Further Perspectives
We expect the next generation of 3D probes to increase the aperture
size to match the currently available 2D probes. This will enable nar-
rower reference beams, enabling multibeam HPRF color Doppler to
measure smaller orifices and narrower and asymmetric functional MR
with less bias. The current low frame rate of about 10 volumes/s is also
expected to increase significantly with the use of parallel received
beams.
CONCLUSION
For the quantification ofMR, calculation of VCAbymultibeamHPRF
color Doppler overcomes several of the limitations of CFI, as well as
the assumptions made by PISA that lead to the underestimation of
noncircular defects. However, multibeam HPRF color Doppler regur-
gitant volume significantly overestimated mild regurgitation, but this
condition can easily be identified as such by standard 2D Doppler ex-
aminations, making further quantitative efforts unnecessary. There
was no significant bias for moderate and severe MR when regurgitant
volume measured by multibeam HPRF color Doppler was compared
with MRI. We believe that multibeam HPRF color Doppler regurgi-
tant volume calculated as the product of VCA and VTI by CWDopp-
ler can supplement 2D Doppler for the quantification of moderate
and severe MR.
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Aims The aim of this study was tovalidate and assess the feasibilityof a previously described method using multibeam high-pulse
repetition frequency (HPRF) colour Doppler to quantify the vena contracta area (VCA) in aortic regurgitation (AR).
Methods Twenty-nine patients with mild to severe AR were studied. Regurgitant volume and fraction measured by magnetic
resonance imaging (MRI) were used as the standard of reference. The VCA was measured automatically by combining
the Dopplerpower frommultiple beams with apriori knowledge of the individual beam profiles, to give anabsolute meas-
urement of the VCA. The regurgitant volume was calculated as the product of the VCA and the velocity time integral,
measured separately by continuous wave Doppler.
Results The Spearman’s rank correlationbetweenregurgitant volume by MRI and multibeam HPRF colour Dopplerwas rs ¼ 0.73
(P, 0.01), with 95% limits of agreement of214.4 + 29.1 mL. The mean difference between the methods in those with
MRI regurgitant volume of ≥30 mL (n ¼ 14) was 27.6 (95% confidence interval 213.9 to 21.2) mL.
Conclusion There was good agreement between MRI and multibeam HPRF colour Doppler in patients with moderate to severe AR,
while agreement for those with mild AR was modest.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Keywords Aortic regurgitation † Multibeam HPRF colour Doppler † 3D colour Doppler † Venacontracta area † Regurgitant
volume
Introduction
The evaluation of aortic regurgitation (AR) with echocardiography
requires an integrated approach of semi-quantitative and quantitative
two-dimensional (2D) Doppler parameters.1,2 Quantitative para-
meters such as the proximal isovelocity surface area to calculate
the effective regurgitant orifice area (ERO area) and regurgitant
volume are recommended when feasible.1 –3 One of the limitations
is the hemispheric assumption of the flow convergence. The vena
contracta is a direct measure of the ERO and correlates to the sever-
ity of AR.4,5 From 3D colour Doppler imaging, we can measure the
vena contracta area (VCA) making no assumptions of the geom-
etry,6 – 8 but these measurements are gain-dependent.
The attenuation compensated volume flowmeter to measure
volume flow in arteries was introduced by Hottinger and Meindl.9
In laminar flow, the backscattered Doppler power is proportional
to the volume of blood in the sample volume of an ultrasound
beam.10 This principle has been used in the quantification of mitral
regurgitation using one measurement beam and one reference
beam.11 We have extended this principle by using multiple narrow
beams (multibeam) to provide a homogenous measurement and
additionally by high-pulse repetition frequency (HPRF) to increase
the Nyquist limit. This method, multibeam HPRF colour Doppler,
has been described and validated in vitro,12 and in patients with
mitral regurgitation to quantify the VCA semi-automatically.13 In
the present study, we have extended the method to perform a fully
* Corresponding author. Tel: +47 728 28 140; Fax: +47 728 28 372, Email: thomas.r.skaug@ntnu.no
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automatic quantification of the VCA, and applied this in patients with
AR. To obtain the regurgitant volume, the VCA was multiplied with
the velocity time integral (VTI), found separately using continuous
wave (CW) Doppler. Our primary aim was to assess agreement
between multibeam HPRF colour Doppler and phase-contrast mag-
netic resonance imaging (MRI).14– 17 Our secondary aim was to
compare the new method with 3D colour Doppler,1,6 and AR
echo grade by 2D Doppler echocardiography.1
Methods
Equipment
A Vivid 7 Dimension or E9 (GE Vingmed Ultrasound, Horten, Norway)
wasused with an M4S orM5S cardiacprobe to acquire2D Dopplerecho-
cardiography images, and we used a 3 V matrix array probe to acquire
multibeam HPRF colour Doppler and 3D colour Doppler images.
EchoPac BT 11 (GE Vingmed Ultrasound) was used to analyse 2D and
3D colour Doppler images. The custom software was used for post-
processing of the raw multibeam HPRF colour Doppler data to calculate
the VCA (MATLAB 7.8.0, Math Works).
Subjects
This study was performed at the Department of Cardiology, St. Olav’s
Hospital, Trondheim University Hospital, Norway, and the Department
of Cardiology, Oslo University Hospital, Rikshospitalet, Norway. The in-
clusion criteriawere adult patients with mild to severe chronicAR in sinus
rhythm. The exclusion criteria were cardiac arrhythmias or any contra-
indication for MRI. Thirty-six subjects with mild to severe chronic AR
consented to participate and successfully underwent the echo and MRI
exams. Due to difficulty in identifying the vena contracta, misalignment
of the Doppler beam and jet direction or incorrect positioning of the
region of interest (ROI) in four subjects with eccentric jets and three sub-
jects with central jets we were not able to measure the VCA by multi-
beam HPRF colour Doppler in 7 of 36 subjects, and these subjects
were excluded from the analyses. There were 7 women and 22 men
with a median age of 58 (range 18–83) years. The aetiology of the AR
were degenerative disease in nine, bicuspid aortic valve in seven, cusp
prolapse in three, aortic root disease in six, and other uncertain mechan-
isms in four subjects. In 16 subjects, there were eccentric jets, and in the
remaining 13, there were central jets. The median ejection fraction mea-
sured by 2D echocardiography was 60 (range 30–71)%. The median left
ventricular end-diastolic and end-systolic dimensions were 61 (range
45–72) mm and 39 (range 25–52) mm, respectively. All echocardio-
graphic recordings were performed immediately before the MRI study.
Median heart rate during Doppler echocardiography was 60 (range
40–92) bpm and that during MRI was 65 (range 43–96) bpm. The
study was approved by the Regional Committee for Medical
and Health Research Ethics and conducted according to the Helsinki
Declaration.
Multibeam HPRF colour Doppler
We used HPRF and a clutter filter to be able to separate the Doppler
signals in the vena contracta from the entrained blood with lower veloci-
ties surrounding the jet. In this study, the Nyquist limit was about 3 m/s,
and we used a clutter filter with a cut-off frequency corresponding to
1.5 m/s. There were several narrow ultrasound beams (multibeam)
spread across the vena contracta region to measure the power of the
vena contracta Doppler signal (Pmeas). To get a calibrated Doppler
power measurement, a reference beam was chosen as the beam with
the most Doppler power (Pref) because this beam was most likely
within the regurgitant jet. A computer model provided the cross-
sectional area (Aref) of the reference beam and a constant (k). The
VCA was proportional to the calibrated Doppler power, and therefore
independent of attenuation, gain or tissue priority, and found by solving:
Pmeas
VCA
= k Pref
Aref
Multibeam HPRF colour Doppler acquisition
and processing
Multibeam HPRF colour Doppler recordings were made from the apical
five-chamber view for the central jets (Figure 1) and from the parasternal
long-axis view for the eccentric jets (Figure 2) to get the best possible
alignment of the ultrasound beams and the regurgitant jet. The vena con-
tracta was located using a triplex-mode, in which the pulsed-wave (PW)
sample volume was moved into the regurgitant jet shown by colour
Doppler imaging, and we used approximately a few minutes to locate
the vena contracta. The scanner was then switched to the multibeam
HPRF colour Doppler mode, with the position of the 3D ROI centred
on the PW sample volume. The transmit frequency was 2.1 MHz. The
ROI was typically at a depth of 5–12 cm during acquisition, and the size
of the ROI was 7 mm × 20 mm × 21 mm. The frame rate was 7–10
HPRF colour volumes per second. A recording consisted of 10–15 heart-
beats of real-time 3D data acquired in less than half a minute. More details
can be found in previous publications.12,13
The multibeam HPRF colour Doppler recordings were analysed using
the custom software to measure the VCA. The output was cross-
sectional Doppler power images of the vena contracta and estimates of
the VCA for each frame. In Figure 3, six diastolic frames of multibeam
HPRF colour Doppler data during a single heartbeat are demonstrated.
The Doppler measurements from all the diastolic framesduring a record-
ing of 10–15 heartbeats were calculated fully automatically, and we used
the median value as the estimate of the VCA. The recordings were vali-
dated by a blinded observer to assure that they were representative con-
sistingof: (i) aDoppler signal above thenoise level and (ii) aDoppler signal
within the ROI. However, there were no manual interactions in order to
calculate the VCA. To assess repeatability, a separate recording from the
same subject was similarly analysed. Regurgitant volume was calculated
as: VCA × VTI measured separately by CW Doppler.
3D colour Doppler
A 3D colour Doppler examination was performed from the parasternal
long-axis view. The Nyquist limit was 60 cm/s. Full-volume of the flow
data was acquired from six consecutive cardiac cycles, and the frame rate
was 15 volumes per second. We used a default clutter filter with a
cut-off frequency corresponding to 20 cm/s. The dataset was cropped
just downstream from the aortic valve in a plane perpendicular to the
aortic regurgitant jet to find the VCA. The frame with the largest area
of the vena contracta was chosen and measured by planimetry. Regurgi-
tant volume was calculated as: VCA × VTI measured separately by CW
Doppler.
2D colour Doppler
We measured the VTI and pressure half time of the regurgitant aortic jet
with CW Doppler from the parasternal long-axis view in eccentric jets
and also from the apical five-chamber view in central jets to get the
best possible alignment of the ultrasound beam and the regurgitant jet.
The colour Doppler sector size was optimized, and the frame with the
largest diameter of the vena contracta was selected to measure the
vena contracta width (VCW). The Nyquist limit was 60 cm/s.
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Assessment of diastolic flow reversal in the descending aorta by PW
Doppler was performed. Further, assessment of the left ventricular func-
tion and dimensions were performed. A cardiologist blinded for the MRI,
multibeam HPRF, and 3D colour Doppler results analysed these data.
Based on qualitative and semi-quantitative parameters, AR severity was
graded as: 1 ¼ mild, 2 ¼ moderate, and 3 ¼ severe.1
MRI study
All patients were examined during supine rest using a Siemens Avanto
1.5-T system with a body matrix coil (Siemens, Erlangen, Germany).
Balanced steady-state free precession cine images were acquired
during end-expiratory breath holds in the long- and short-axis views of
the left ventricle. Flow in the ascending aorta, at the level of the right
pulmonary artery,15 was quantified using a steady-state free precession
phase-contrast sequence. The image was aligned perpendicular to the
vessel walls guided by two previously acquired perpendicular cine
images positioned along the centre of the ascending aorta. The following
settings were used: end-expiratory breath hold, retrospective ECG-
gating, in-plane resolution 1.3 × 1.3 mm, minimal TR (61.05 ms) and
TE (3.09 ms), slice thickness 6 mm, Venc adjusted to just above maximal
systolic velocities, and 30 frames/beat. All images were analysed in
Segment18 by one observer unaware of the echocardiographic results.
Systolic and diastolic flow in the ascending aorta was quantified from
the phase-contrast images by drawing an ROI in the reconstructed mag-
nitude images. The aortic regurgitant volume during diastole was quanti-
fied, and the regurgitant fraction wascalculatedbydividing the regurgitant
Figure 2: Two-step multibeam HPRF colour Doppler data
acquisition with triplex scan (upper panel) and multibeam HPRF
colour flow of the vena contracta (lower panel) from the paraster-
nal long-axis view in eccentric AR.
Figure 1: Two-step multibeam HPRF colour Doppler data
acquisition with triplex scan (upper panel) and multibeam HPRF
colour flow of the vena contracta (lower panel) from the apical five-
chamber view in central AR.
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volume with the forward volume during systole. This approach will over-
estimate the regurgitant volume slightly as coronary flow during diastole
will be included. We sought to reduce phase-offset errors in the velocity
measurements by positioning the phase-contrast image in isocentre, and
using as low Venc as possible.
19
Statistics
Descriptive values are reported as median and range, and Spearman’s
rank correlation (rs) was used because the continuous variables were
not normally distributed.
Because the differences were normally distributed, we used paired
sample t-test to compare the VCA and regurgitant volume, respectively,
by thedifferentmethods. The level of significancewaschosen at P, 0.05.
The agreement between the continuous variables was assessed by
calculating the 95% limits of agreement (mean difference+2 SD). The
mean difference between two methods was reported as 95% confidence
interval (CI).
To assess the agreement between AR echo grade and VCA, we
used kappa statistics. According to current recommendations for the
ERO area by 2D echo Doppler, we divided multibeam HPRF colour
Doppler VCA into: 1¼ ,10 mm2, 2¼ 10–29 mm2, and 3¼ ≥30 mm2.1
In accordance with proposed cut-offs by Chin et al.,7 we divided 3D
colour Doppler VCA into: 1 ¼ ,30 mm, 2 ¼ 30–49 mm2, and 3 ¼ ≥
50 mm2.
Repeatability of the multibeam HPRF colour Doppler VCA in separate
recordingswasassessedas thecoefficient of repeatability, definedas2SD
of the differences.
The statistical analyses were performed using SPSS Statistics 19 (SPSS,
Inc., Chicago, IL, USA).
Results
The descriptive results are presented in Table 1, and the Spearman’s
rank correlation between the different methods is presented in
Table 2. The mean difference between the heart rate during the
MRI and Doppler echocardiography was 3.6 (95% CI 1.0–6.1) bpm.
There was a better correlation between VCA measured by multi-
beam HPRF colour Doppler or 3D colour Doppler and MRI regurgi-
tant fraction than between VCW and MRI regurgitant fraction
(Table 2 and Figure 4). The Spearman’s rank correlation and the
95% limits of agreement between MRI regurgitant volume and multi-
beam HPRF colour Doppler VCA × VTI were rs ¼ 0.73 (P, 0.01)
and214.4+ 29.1 mL, respectively (Figure 5A). The mean differences
between the methods in groups based on direction of the jet and AR
severity are presented in Table 3. The Spearman’s rank correlation
and the 95% limits of agreement between MRI regurgitant volume
and 3D colour Doppler VCA × VTI were rs ¼ 0.75 (P, 0.01) and
247.8+ 60.9 mL, respectively (Figure 5B), while between 3D
colour Doppler and multibeam HPRF colour Doppler VCA there
were rs ¼ 0.74 and 13.3+ 20.3 mm2 (Figure 5C).
Based on AR echo grading, there was mild AR in 9, moderate AR in
8, and severe AR in 12 subjects. There was a good correlation
between AR echo grade and VCA by both multibeam HPRF colour
Doppler and 3D colour Doppler, and agreement was L ¼ 0.50
(P, 0.01) andL ¼ 0.64 (P, 0.01), respectively (Figure 6).
The analysis of the VCA estimate was made fully automatically, and
consequently, there was no inter- or intraobserver variability. In a
separate recording from the same subject, the coefficient of repeat-
ability for multibeam HPRF colour Doppler VCA estimates was
9.4 mm2.
Discussion
The present study showed that fully automatic calculation of the VCA
in AR was feasible using multibeam HPRF colour Doppler, and that
the correlation with MRI regurgitant volume and fraction was
good. Similar to other echocardiographic methods, the major clinical
advantages of multibeam HPRF colour Doppler vs. MRI are availabil-
ity and no contraindications. According to the ESC guidelines, in
patients with inadequate echocardiographic quality or discrepant
results, MRI should be used to assess the severity of valvular
lesions, particularly regurgitant lesion.2 Interestingly, both 3D
methods, multibeam HPRF colour Doppler and 3D colour
Doppler VCA, were more closely correlated to MRI regurgitant
volume and fraction than VCW, measured in 2D. This is in line with
Figure 3: Multibeam HPRF colour Doppler flow from the vena contracta during one heartbeat, and six diastolic frames are depicted. This
recording was obtained from the parasternal long-axis, as shown in Figure 2.
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Perez de Isla et al.8 who demonstrated better accuracy with 3D
colour Doppler VCA than 2D Doppler to assess AR severity,
defined by MRI parameters. The regurgitant volume calculated
from multibeam HPRF colour Doppler and CW Doppler overesti-
mated the severity of AR compared with MRI, but the agreement
between the methods was better for those with MRI regurgitant
volume of ≥30 mL compared with those with MRI regurgitant
volume of ,30 mL. The regurgitant volume calculated from 3D
colour Doppler and CW Doppler significantly overestimated the se-
verity compared with MRI, and the limits of agreement between MRI
and 3D colour Doppler was wider than between MRI and multibeam
HPRF colour Doppler. In a recent study, Ewe et al.20 found excellent
agreement between 3D colour Doppler and MRI. These results dif-
fered from ours, for both 3D methods. There may be several
reasons for this. In our study, the heart rate during MRI was slightly
higher than during Doppler, which could contribute to some over-
estimation by both 3D methods. We measured VTI by CW
Doppler from the apical view in central AR and the parasternal
view in eccentric AR, as recommended.1 Ewe et al. measured VTI
from the apical view in eccentric and central AR. Ultrasound beam
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Descriptive results
Parameter Median Range
MULDO VCA (mm2) (N ¼ 29) 17.0 6.0–43.0
In central AR (n ¼ 13) 16.0 9.0–32.0
In eccentric AR (n ¼ 16) 19.5 6.0–43.0
3D colour Doppler VCA (mm2) (N ¼ 29) 35 12–60
In central AR (n ¼ 13) 20 12–50
In eccentric AR (n ¼ 16) 40 12–60
VCW (mm) (N ¼ 29) 5 2–12
In central AR (n ¼ 13) 4 3–7
In eccentric AR (n ¼ 16) 6 2–12
VTI (cm) (N ¼ 29) 250 109–430
In central AR (n ¼ 13) 250 135–430
In eccentric AR (n ¼ 16) 248 109–387
MULDO VCA × VTI (mL) (N ¼ 29) 41.7 12.0–83.7
In central AR (n ¼ 13) 39.8 17.8–75.6
In eccentric AR (n ¼ 16) 45.1 12.0–83.7
3D colour Doppler VCA × VTI (mL) (N ¼ 29) 65.0 23.8–168.0
In central AR (n ¼ 13) 52.8 23.8–150.5
In eccentric AR (n ¼ 16) 97.8 24.0–168.0
MRI regurgitant volume (mL) (N ¼ 29) 25.0 2.3–87.8
In central AR (n ¼ 13) 19.0 2.3–58.1
In eccentric AR (n ¼ 16) 38.0 3.0–87.8
MRI regurgitant fraction (%) (N ¼ 29) 23.1 4.4–77.0
In central AR (n ¼ 13) 19.1 4.4–77.0
In eccentric AR (n ¼ 16) 33.9 4.4–50.2
MULDO VCA × VTI calculates regurgitant volume.
3D colour Doppler VCA × VTI calculates regurgitant volume.
MULDO, multibeam HPRF colour Doppler; VCA, vena contracta area; AR, aortic
regurgitation; VCW, vena contracta width by 2D colour Doppler; VTI, velocity time
integral of the aortic regurgitant jet by CW Doppler.
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Table 2 Correlation
Spearman’s rank correlation rs P-value
MULDO VCA (mm2)
vs. MRI regurgitant fraction (%) 0.77 ,0.01
vs. MRI regurgitant volume (mL) 0.81 ,0.01
vs. 3D colour Doppler VCA (mm2) 0.74 ,0.01
vs. echo grade (mild, moderate, and severe) 0.76 ,0.01
MULDO VCA × VTI (mL)
vs. MRI regurgitant fraction (%) 0.67 ,0.01
vs. MRI regurgitant volume (mL) 0.73 ,0.01
vs. echo grade (mild, moderate, and severe) 0.67 ,0.01
3D colour Doppler VCA (mm2)
vs. MRI regurgitant fraction (%) 0.83 ,0.01
vs. MRI regurgitant volume (mL) 0.87 ,0.01
vs. echo grade (mild, moderate, and severe) 0.76 ,0.01
Echo grade (mild, moderate, and severe)
vs. MRI regurgitant fraction (%) 0.71 ,0.01
vs. MRI regurgitant volume (mL) 0.78 ,0.01
VCW (mm)
vs. MRI regurgitant fraction (%) 0.68 ,0.01
vs. MRI regurgitant volume (mL) 0.75 ,0.01
MULDO VCA × VTI calculates regurgitant volume.
Echo grade, severity of aortic regurgitation by 2D Doppler parameters.
MULDO, multibeam HPRF colour Doppler; VCA, vena contracta area; VCW, vena
contracta width by 2D colour Doppler; VTI, velocity time integral of the aortic
regurgitant jet by CW Doppler.
Figure 4: Comparison of the VCA by multibeam HPRF colour
Doppler (MULDO) and 3D colour Doppler vs. MRI regurgitant
fraction. The Spearman’s rank correlation was rs ¼ 0.77 and 0.83,
respectively.
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misalignment can underestimate the VTI and the regurgitant volume.
We performed the 3D colour Doppler acquisition fromthe paraster-
nal view, and Eweet al.usedboth the apical andparasternal views. We
used the frame with the largest VCA, while Ewe et al. used the frame
‘with the most relevant lesion size’. Furthermore, scanners and
probes were different.
The VCA measured by 3D colour Doppler was significantly higher
than by multibeam HPRF colour Doppler, and this explains the
differences in regurgitant volume by the two 3D methods in our
study. There were several differences between these methods.
Most importantly, the HPRF and clutter filter in the proposed
method enabled the isolation of the high-velocity core of the vena
contracta, in contrast to regular low-PRF colour Doppler, which
also measured low-velocity entrained blood. The clutter filter
cut-off frequency corresponded to 1.5 m/s for multibeam HPRF
colour Doppler and 0.2 m/s for 3D colour Doppler. Secondly, in
Figure 5: The correlation and Bland–Altman plots of (A) the regurgitant volume (Reg.Vol.) measured by MRI and multibeam HPRF colour
Doppler (MULDO) VCA × VTI, (B) the regurgitant volume (Reg.Vol.) measured by MRI and 3D colour Doppler VCA × VTI, and (C) VCA by
3D colour Doppler and multibeam HPRF colour Doppler.
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3D colour Doppler, it was common to reduce the lateral resolution
somewhat to gain some extra frame rate. The multibeam HPRF
colour Doppler algorithm automatically compensated for the over-
estimation due to limited lateral resolution as long as the reference
beam was within the vena contracta jet. Altering the display para-
meters such as gain and tissue priority during acquisition did not
affect the multibeam HPRF colour Doppler data. The 3D colour
Doppler was gain-dependent, and the width and area of a regurgitant
orifice could be overestimated with approximately one beam width
in each direction (azimuth and elevation). Furthermore, each record-
ing of multibeam HPRF colour Doppler consisted of 10–15 heart-
beats of real-time full-volume datasets, while the 3D colour
Doppler dataset was reconstructed from several heartbeats of sub-
volumes to make a full volume, which can predispose to stitching
artefacts and overestimation of the VCA. The measurements of the
Doppler power in all the diastolic frames in a multibeam HPRF
colour Doppler recording were fully automatic, and the median
value of these measurements was chosen as the VCA. The 3D
colour Doppler dataset post-processing on the other hand consisted
of sequential cropping of the regurgitant jet, manual tracing, and the
framewith the largest area of the venacontractawas chosen, similarly
to VCW.1 Dynamic variations of the regurgitant orifice area could be
another contributing factor for the differences in the VCA measure-
ments. Using the frame with the largest VCA in 3D colour Doppler,
with a frame rate of15 volumes per second, and the median VCA of
several measurements in multibeam HPRF colour Doppler, with a
frame rate of 7–10 volumes per second, could enhance this con-
founding effect.
Semi-quantitative echo Doppler methods are part of an integrated
approach to grade AR.1 Chin et al.7 demonstrated good correlation
between 3D colour Doppler VCA and AR severity assessed by
Doppler methods. They proposed cut-off values for 3D colour
Doppler VCA of 30 and 50 mm2 for mild and severe AR, respectively,
and we used these cut-offs to assess agreement between AR echo
grade and 3D colour Doppler VCA. To assess agreement between
multibeam HPRF colour Doppler VCA and AR echo grade, we
chose the reference values for the ERO area by quantitative
Doppler. Agreement between AR echo grade and VCA by both 3D
colour Doppler and multibeam HPRF colour Doppler, however,
based on different reference values, was moderately good.
Limitations
From MRI aortic phase contrast, we calculated regurgitant volume
and fraction, but there are different reference values for regurgitant
fraction to assess severity.14,15 The Nyquist limit of3 m/s for multi-
beam HPRF colour Doppler is usually lower than the maximum
aortic regurgitant jet velocity. However, as long as the peak velocity
is less than two times the Nyquist velocity and the direction of the
jet is known, the velocity of the regurgitant jet can be determined un-
ambiguously. The size of the ROI is small to achieve this Nyquist limit.
Unlike 3D colour Doppler with a large colour Doppler sector where
you can do the analysis and cropping of the vena contracta online,
correct positioning of the small ROI of multibeam HPRF colour
Doppler in the vena contracta region is essential during acquisition.
In 7 of the 36 subjects in this study, we were not able to acquire
representative Doppler data, because of difficulty in identifying the
vena contracta, misalignment or incorrect positioning of the small
ROI outside the vena contracta, or possibly if the valve was at a
depth which made one of the transmitted HPRF pulses too close
(in time) to the receiver, such that it was saturated. Other clinical
limitations are inability to hold the breath for 10–15 s causing
respiratory movements and displacement of the ROI during acquisi-
tion, poor acoustic windows, or heavy valvular calcification causing
attenuation of the Doppler signals. Owing to the current frame
rate, tachyarrhythmia can as well be a limitation.
Previous studies have demonstrated that multibeam HPRF colour
Doppler using the semi-automatic approach overestimates mild re-
gurgitation.12,13 This is also in correspondence with current findings
in AR for this fully automatic approach. Acquisition parameters such
as transmit frequency and pulse repetition frequency will affect the
lateral resolution and the Nyquist limit. Multibeam HPRF colour
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Themean differences between regurgitant
volume by MRI and multibeam HPRF colour Doppler
(MULDO) in subgroups
MRI vs. MULDO
Reg.Vol. (mL)
Mean
difference
95% CI
In central jets (n ¼ 13) 220.3 231.2 to 29.4
In eccentric jets (n ¼ 16) 29.6 214.4 to 24.7
In those with MRI Reg.Vol.
of ,30 mL (n ¼ 15)
220.7 229.0 to 212.5
In those with MRI Reg.Vol.
of ≥30 mL (n ¼ 14)
27.6 213.9 to 21.2
Figure 6: Comparison between echo grade and VCA by
multibeam HPRF colour Doppler and 3D colour Doppler.
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Doppler will overestimate the VCA when the regurgitant orifice is
small relative to the reference beam and when the reference beam
is not entirely within the regurgitant orifice.
The frame rate of 7–10 volumes per second is too low to
acquire accurate VTI from the multibeam HPRF colour Doppler
data. To quantify aortic regurgitant volume, we measured VTI separ-
ately by CW Doppler and VCA by multibeam HPRF colour Doppler.
Using different probes and separate acquisitions raise the possibility
for differences in beam alignment and thus error in calculating the
regurgitant volume. However, we used the parasternal window in
eccentric jets and the apical window in central jets, respectively, for
both acquisitions to try to minimize such errors.
Further perspectives
Future generations of 3D probes are expected to have improved
resolution, which will make it possible to obtain better estimates
for the calibration beam necessary for multibeam HPRF colour
Doppler. The trend of plane wave imaging promises ‘ultrafast’
frame rates, but with some reduction in spatial resolution. With an
increased frame rate, regurgitant volume could be derived directly
from the multibeam HPRF colour Doppler dataset. Large transdu-
cers with numerous parallel beam formers will probably lead the
way to creative combinations of the raw HPRF Doppler data that
might solve some of the current limitations. With 3D TEE probes,
there will be in closer approximation to the valvular defect, thus
increased resolution, less reverberation, and better estimate of the
VCA. Studies are needed to assess clinical outcome.
Conclusion
Quantification of AR with multibeam HPRF colour Doppler was
feasible. Multibeam HPRF colour Doppler with automatic calculation
of the VCAovercomes manyof the limitations of 3D colour Doppler.
There was good agreement between regurgitant volume measured
by MRI and multibeam HPRF colour Doppler in patients with
moderate to severe AR, while agreement for those with mild AR
was modest. Agreement between VCA and AR echo grade was
moderately good.
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